NPPA Ceiling Price Report

National Pharmaceutical Pricing Authority
3rd
Floor, YMCA Cultural Centre
1 Jai Singh Road, New Delhi 110001
Injeti Srinivas, IAS
Chairman
27 February 2015
PREFACE
The National Pharmaceutical Pricing Authority (NPPA) is mandated with the task
of implementing the Drugs (Prices Control) Order (DPCO) 2013, which aims at making
available all essential and lifesaving medicines to all at affordable prices through the
instrumentality of price control. Drug price control is not something peculiar to India, but
one that is prevalent in most countries, including many developed countries, though the
methodology of price control may differ from one country to another.
2. Unlike the DPCO 1995, which adopted a cost-based approach for price fixation in
respect of scheduled drugs, the DPCO 2013 adopts a market-based approach for price
fixation. Second, the National List of Essential Medicines (NLEM) 2011 is adopted as the
primary basis for determining essentiality, and is accordingly incorporated in the First
Schedule to the DPCO 2013, which constitutes the list of scheduled medicines for the purpose
of price control. Third, the price control is applied to specific formulations with reference to
the medicine (active pharmaceutical ingredient), route of administration/ dosage form and
strength as contained in the First Schedule.
3. Under the market-based approach, the ceiling price of a scheduled drug is determined
by first working out the simple average of price to retailer (PTR) in respect of all branded-
generic and generic versions of that particular drug formulation having a market share of 1
percent and above, and then adding a notional retailer margin of 16 percent to it. The
maximum retail price (MRP) for that particular drug formulation must not exceed the
notified ceiling price plus applicable local taxes.

3rd
4. All the existing manufacturers (including importers and marketers) of a scheduled
formulation, selling branded or generic or both versions of that formulation at a price higher
than the ceiling price plus local applicable taxes are required to reduce it to at least that
level. At the same time, all existing manufacturers (including importers and marketers) of
that formulation who are selling it below that price are required to maintain their existing
MRP. Implementation of the price notification is to be communicated, in Form-V of Schedule
II to the DPCO 2013, to all dealers, State Drug Controllers and NPPA immediately. Also the
current price list of scheduled drugs has to be displayed by every dealer and retailer.
5. The ceiling price fixed for each scheduled formulation becomes operative and legally
enforceable from the date on which the price is notified in the Gazette of India Extraordinary.
In other words, the medicine cannot be sold at an MRP exceeding the ceiling price plus
applicable local taxes from the date of price notification. However, for stock manufactured
or available in the market prior to publication of the ceiling price, a grace period of 45 days
is available to facilitate recall and/ or reprinting of the revised MRP on the label of the
medicine in accordance with the notified ceiling price. But under no circumstances does it
allow sale of a medicine at the pre-revised price even during the 45-day grace period, as the
same stock keeping unit (SKU) of a particular medicine should not be offered to the consumer
at a price exceeding the price specified in the current price list or the price indicated on the
label of the medicine pack, whichever is less. Similarly, all batches manufactured after the
price notification must necessarily conform to the notified ceiling price.
6. The notified ceiling price with respect to each scheduled formulation is valid for a
period of five years from the date of original price notification, but subject to annual revision
to be notified by NPPA which would be effective from the first day of April every year as
per the annual wholesale price index (WPI) notified by the Department of Industrial Policy
& Promotion with respect to the previous calendar year. The revision may mean increase or
decrease in ceiling price depending upon whether the WPI is positive or negative. The
manufacturers (including importers and marketers) are free to avail themselves of the annual
revision in case of increase, without obtaining prior approval of the Government, but they
are required to exercise their decision in this regard within 15 days of such revision and
report to the NPPA in Form-II of Schedule II to DPCO 2013 failing which it shall be construed
that the company has opted for non-revision of MRP and the concerned manufacturer shall

3rd
be liable to deposit the amount charged over and above the pre-revised MRP, along with
interest from the date of overcharging. Further, they shall be bound to decrease their MRP
correspondingly in case of decrease in the ceiling price due to negative WPI.
7. Non-compliance with the notified ceiling price or, in other words, the MRP breaching
ceiling price plus applicable local taxes would be tantamount to overcharging the consumer,
which is liable to be recovered along with interest thereon from the date of overcharging.
The excess collection on account of overcharging along with interest is recoverable as arrears
to land revenue under the Public Demand Recovery Act.
8. Further, non-compliance of price notification issued by NPPA, depending upon the
gravity of the offence, could also attract prosecution under the Essential Commodities Act
(ECA), 1955. Section 7 of the ECA 1955 provides for imprisonment for a term which shall
not be less than 3 months, but which may extend to seven years and shall also be liable for
fine. Section 9 of the ECA, 1955 makes false statements/ information also punishable with
imprisonment for a term which may extend to five years or with fine or with both. Under
section 10 of the ECA, 1955, offences committed by companies are punishable, and shall
apply to every person who, at the time the contravention was committed, was in charge of,
and was responsible to, the company for conduct of the business of the company as well as
the company, shall be deemed to be guilty of the contravention and shall be liable to be
proceeded against and punished accordingly. Every offence committed under the Essential
Commodities Act, 1955 is a cognizable offence.
9. Implementation of the DPCO 2013 is the joint responsibility both NPPA and State
Drug Controllers. Accordingly, most State Governments/ Union Territories have duly
empowered the State Drug Controller and Drug Inspectors under paragraph 30 (1) of DPCO
2013, which allows any Gazetted Officer of the Central Government or of a State
Government, as the case may be, to exercise the power of entry, search and seizure to ensure
that the provisions of the DPCO have been complied with. The States which are yet to do
this are requested to do so at the earliest. Further, as part of the regular enforcement activity
of the Office of the State Drug Controller, on similar lines as done with respect to drug
sample testing under the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules,
1945, every Drug Inspector should be given a monthly target for purchasing scheduled
formulations, preferably 5 to 10 samples a month, to verify price compliance, and report

3rd
price violations for taking necessary action against erring manufacturers, importers,
marketers, and dealers (including retailers). The State Drug Controller may compile the
monthly reports of individual Drug Inspectors, and submit a monthly consolidated report
to NPPA in the following format:-.
The report should be accompanied with supporting documents such as photocopy of sample
pack with MRP, Batch No. and Manufacturing date, Name of Manufacturer and Marketer
(if applicable). While collecting samples from the market, preference may be given to those
formulations that are of mass consumption; each sample may be procured from 2 to 3
locations in order to get a geographical spread. Finally, the samples collected should
correspond to important therapeutic groups in relation to disease burden in the State. This
activity should be taken up with utmost sincerity in order to prevent consumer exploitation
and protect public interest
10. At present the DPCO 2013 contains 680 scheduled drug formulations spread across
27 therapeutic groups, which effectively comes to 628 scheduled drug formulations if we
net those appearing in more than one therapeutic group. As on date, the NPPA has fixed
and notified the ceiling prices with respect to 509 scheduled formulations, apart from
notification of annual WPI-linked revision whenever due. With regard to the remaining
119 scheduled drug formulations, 17, which are common to both DPCO 1995 and DPCO
2013, are not yet due for revision. With respect to the residual 102 scheduled drug
formulations, the NPPA has not been able to fix the ceiling prices due to non-availability of
corresponding market-based PTR data, efforts for which are continuously on, and those
ceiling prices shall be notified as soon as the said data is available.
11. TheCompendiumofNotifiedCeilingPricesofScheduledDrugs2015hasbeenbrought
out with the objective of disseminating information related to notified ceiling prices in respect
of scheduled drugs, to all stakeholders, particularly consumers and consumer welfare
Sl.No. Name and
address of
Manufacturer
and Marketer
in case of
separate
entities
Brand
Name, if
any
Pack
Size
Batch No. and
manufacturing
date
Maximum
Retail
Price
(MRP)
Ceiling
Price/
unit
Gazette
Notification
No. and
date
Remarks
(1) (2) (3) (4) (5) (6) (7) (8) (9)

organisations/ NGOs; manufacturers, including importers and marketers of
pharmaceuticals products; stockist/ distributors, dealers and retailers; doctors and public
health experts; and most importantly enforcement functionaries (NPPA, State Drug
Controller and Drug Inspectors) for carrying out monitoring and enforcement activities.
Apart from serving as a compendium of notified ceiling prices, it is also expected to help in
propagating the NLEM, which is basically aimed at promoting scientific and rational use of
medicines that is both clinically-effective and cost-effective.
12. I sincerely hope that all stakeholders will find this compendium extremely useful as
a ready reckoner. The enforcement functionaries may find this compendium useful in
carrying out monitoring and enforcement activities with regard to price compliance under
DPCO 2013. The NPPA has provided on its website an online facility to lodge complaints
related to price and availability of pharmaceuticals, which may be used by consumers, NGOs
and enforcement functionaries to report cases of overcharging or non-availability of
medicines, if any. A soft copy of the compendium is also placed on the NPPA website
www.npppaindia.nic.in along with copies of related Gazette of India Extraordinary price
notifications in PDF format. Although every effort has been made to maintain accuracy in
the compendium, the NPPA shall not be responsible for any error or mistake that may have
inadvertently crept into the compendium. The reader is, therefore, advised to refer to the
relevant official Gazette notification before taking any action on the basis of this
compendium.
(Injeti Srinivas)
3rd

DISCLAIMER
Theinformationcontainedhereinisnotasubstitute
to ceiling prices notified in the Gazette of India
Extraordinary. For the official version, please refer
to the relevant Gazette Notification issued in this
regard, which may be accessed from the NPPA
website at www.nppaindia.nic.in.

SCHEDULE-I
[Refer Paragraph 2(t), 2(zb)] of DPCO, 2013
NATIONAL LIST OF ESSENTIAL MEDICINES 2011
SECTION : 1 - ANESTHESIA
1.1 General Anesthetics and Oxygen
Sl. No. Medicines Route of Strengths Unit Ceiling Price S.O. Date of
Adminstration/ (Rs.) No. Notification
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
(i) Ether Inhalation –
(ii) Halothane with vaporizer Inhalation – 1ml 5.87 1542(E) 14.06.2013
1ml 6.24 1156(E) 28.04.2014
1ml 6.48 619(E) 26.02.2015
(iii) Isoflurane Inhalation – 1ml 10.73 2230E) 22.07.2013
1ml 11.41 1156(E) 28.04.2014
1ml 11.85 619(E) 26.02.2015
(iv) Ketamine Hydrochloride Injection 10mg/ml 1ml 10.54 3126(E) 10.12.2014
1ml 10.95 619(E) 26.02.2015
(v) Injection 50mg/ml 1ml 10.46 1543(E) 14.06.2013
1ml 11.12 1156(E) 28.04.2014
1ml 11.55 619(E) 26.02.2015
(vi) Nitrous Oxide Inhalation – Cubic Meter 206.18 3762(E) 20.12.2013
Cubic Meter 219.21 1156(E) 28.04.2014
Cubic Meter 227.65 619(E) 26.02.2015
(vii) Oxygen Inhalation – Cubic Meter 15.81 3763(E) 20.12.2013
Cubic Meter 16.81 1156(E) 28.04.2014
Cubic Meter 17.46 619(E) 26.02.2015
(viii) Thiopentone Sodium Injection 0.5 gm powder Each Pack 41.67 1544(E) 14.06.2013
Each Pack 44.30 1156(E) 28.04.2014
Each Pack 46.01 619(E) 26.02.2015
Injection 1 gm powder 1 gm 46.88 3354(E) 05.11.2013
1 gm 49.84 1156(E) 28.04.2014
1 gm 51.76 619(E) 26.02.2015
Added Medicines
(x) Sevoflurane Inhalation – 1 ml 27.99 2850(E) 20.09.2013
1 ml 29.76 1156(E) 28.04.2014
1 ml 30.91 619(E) 26.02.2015
- 1 -
Note :
The mentioned S.O. No. 619(E) dated 26.2.2015 in this compendium is applicable
ceiling prices as per Wholesale Price Index (WPI) effective from 1st April, 2015.

(xi) Propofol Injection 1% oil Each Pack 7.94 1545(E) 14.06.2013
suspension 1ml 2535(E) 02.12.2013
1 ml 8.64 3566(E) 02.12.2013
1 ml 9.19 1156(E) 28.04.2014
1 ml 9.54 619(E) 26.02.2015
1.2 Local Anesthetics
(i) Bupivacaine Hydrochloride Injection 0.25% 1 ml 2.31 2851(E) 20.09.2013
1 ml 2.46 1156(E) 28.04.2014
1 ml 2.55 619(E) 26.02.2015
(ii) Bupivacaine Hydrochloride Injection 0.5% 1 ml 3.49 2852(E) 20.09.2013
1 ml 3.71 1156(E) 28.04.2014
1 ml 3.85 619(E) 26.02.2015
(iii) Bupivacaine Hydrochloride Injection 0.5% to be mixed 1 ml 5.73 2853(E) 20.09.2013
with 7.5% 1 ml 6.09 1156(E) 28.04.2014
glucose solution 1 ml 6.32 619(E) 26.02.2015
(iv) Lignocaine Hydrochloride Topical Forms 2-5% 1 ml / gm 1.18 2854(E) 20.09.2013
1 ml / gm 1.25 1156(E) 28.04.2014
1 ml / gm 1.30 619(E) 26.02.2015
Injection 1-2%
1% Each Pack 6.87 3376(E) 05.11.2013
Each Pack 7.30 1156(E) 28.04.2014
Each Pack 7.58 619(E) 26.02.2015
2% 1 ml 1.00 2248(E) 22.07.2013
1 ml 1.06 1156(E) 28.04.2014
1 ml 1.10 619(E) 26.02.2015
Spinal 5%+7.5%
Glucose
(v) Lignocaine Hydrochloride Injection 1%+ Each Pack 0.68 1546(E) 14.6.2013
+ Adrenaline 1:200,000 Each Pack 0.72 1156(E) 28.04.2014
Each Pack 0.75 619(E) 26.02.2015
(vi) Lignocaine Hydrochloride Injection 2%+ 1 ml 0.57 2855(E) 20.09.2013
+ Adrenaline 1:200,000 1 ml 0.92 923(E) 27.03.2014
1 ml 0.98 1156(E) 28.04.2014
1 ml 1.02 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 2 -
Note :

Added Medicines
(vii) EMLA cream Cream – 1 gm 20.08 1547(E) 14.06.2013
1 gm 21.35 1156(E) 28.04.2014
1 gm 22.17 619(E) 26.02.2015
1.3 Preoperative Medication and Sedation for Short Term Procedures
(i) Atropine Sulphate Injection 0.6 mg/ml 1 ml 4.01 1548(E) 14.06.2013
1 ml 4.26 1156(E) 28.04.2014
1 ml 4.42 619(E) 26.02.2015
(ii) Diazepam Tablets 5 mg 1 Tablet 1.32 1832(E) 21.06.2013
1 Tablet 1.40 1156(E) 28.04.2014
1 Tablet 1.45 619(E) 26.02.2015
Diazepam Injection 5 mg / ml 1 ml 5.59 1549(E) 14.06.2013
1 ml 5.94 1156(E) 28.04.2014
1 ml 6.17 619(E) 26.02.2015
Diazepam Syrup 2mg/5ml
Diazepam Suppository 5 mg 1 Suppository 5.48 3128(E) 10.12.2014
1 Suppository 5.69 619(E) 26.02.2015
(iii) Midazolam Injection 1 mg / ml 1ml 5.79 1550(E) 14.06.2013
1ml 6.16 1156(E) 28.04.2014
1ml 6.40 619(E) 26.02.2015
5 mg / ml 1ml 24.78 1551(E) 14.06.2013
1ml 26.35 1156(E) 28.04.2014
1ml 27.36 619(E) 26.02.2015
(iv) Morphine Sulphate Injection 10 mg / ml 1ml 21.52 2856(E) 20.09.2013
1ml 22.88 1156(E) 28.04.2014
1ml 23.76 619(E) 26.02.2015
(v) Promethazine Syrup 5 mg / 5 ml 1 ml 0.21 1552(E) 14.06.2013
Syrup/Elixir 3574(E) 02.12.2013
1 ml 0.22 1156(E) 28.04.2014
1 ml 0.23 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 3 -
Note :

Section: 2 - Analgesics , Antipyretics, Nonsteroidal Anti-inflammatory Medicines,
Medicines used to treat Gout and Disease Modifying Agents used in
Rheumatoid Disorders
2.1: Non-Opioid Analgesics, Antipyretics and Nonsteroidal Anti-inflammatory Medicines
(i) Acetyl SalicylicAcid Tablets 325mg 1 Tablet 0.44 2360(E) 15.09.2014
1 Tablet 0.46 619(E) 26.02.2015
Acetyl SalicylicAcid Tablets 350 mg
(ii) Diclofenac Tablets 50 mg 1 Tablet 1.95 1909(E) 28.06.2013
1 Tablet 2.07 1156(E) 28.04.2014
1 Tablet 2.15 619(E) 26.02.2015
Injection 25 mg / ml 1 ml 1.53 1910(E) 28.06.2013
1 ml 1.49 2869(E) 20.09.2013
1 ml 1.58 1156(E) 28.04.2014
1 ml 1.64 619(E) 26.02.2015
(iii) Ibuprofen Tablets 200 mg
Tablets 400 mg
Syrup 100mg/5ml 1 ml 0.21 946(E) 27.03.2014
1 ml 0.22 2095(E) 20.08.2014
1 ml 0.23 619(E) 26.02.2015
(iv) Paracetamol Injection 150 mg / ml 1ml 3.29 1553(E) 14.06.2013
1ml 3.43 3567(E) 02.12.2013
1ml 3.65 1156(E) 28.04.2014
1ml 3.79 619(E) 26.02.2015
Syrup 125 mg / 5ml 1 ml 0.33 1554(E) 14.06.2013
1 ml 0.32 421(E) 17.02.2014
1 ml 0.34 1156(E) 28.04.2014
1 ml 0.35 619(E) 26.02.2015
Tablets 500 mg 1 Tablet 0.94 1555(E) 14.06.2013
1 Tablet 1.00 1156(E) 28.04.2014
1 Tablet 1.04 619(E) 26.02.2015
Suppository 80 mg 1 Suppository 4.88 1556(E) 14.06.2013
1 Suppository 6.96 3568(E) 02.12.2013
1 Suppository 7.40 1156(E) 28.04.2014
1 Suppository 7.68 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 4 -
Note :

1 Suppository 8.07 3569(E) 02.12.2013
1 Suppository 8.58 1156(E) 28.04.2014
1 Suppository 8.91 619(E) 26.02.2015
2.2 Opioid Analgesics
(i) Morphine Sulphate Injection 10 mg / ml 1ml 21.52 2856(E) 20.09.2013
1ml 22.88 1156(E) 28.04.2014
1ml 23.76 619(E) 26.02.2015
1 Tablet 5.36 1156(E) 28.04.2014
1 Tablet 5.57 619(E) 26.02.2015
(ii) Tramadol Injection 50 mg/ml 1 ml 11.73 2231(E) 22.07.2013
1 ml 12.47 1156(E) 28.04.2014
1 ml 12.95 619(E) 26.02.2015
Capsule 50 mg 1 Capsule 6.12 1872(E) 28.06.2013
1 Capsule 6.51 1156(E) 28.04.2014
1 Capsule 6.41 1788(E) 10.07.2014
1 Capsule 6.66 619(E) 26.02.2015
Capsule 100 mg
(iii) Fentanyl Injection 50µg/ml (2ml 1 ml 20.26 1558(E) 14.06.2013
ampoule) 1 ml 21.54 1156(E) 28.04.2014
1 ml 22.37 619(E) 26.02.2015
2.3 Medicines used to treat Gout
(i) Allopurinol Tablets 100 mg 1 Tablet 2.09 2830(E) 20.09.2013
1 Tablet 2.22 1156(E) 28.04.2014
1 Tablet 2.31 619(E) 26.02.2015
(ii) Colchicine Tablets 0.5 mg 1 Tablet 2.88 1559(E) 14.06.2013
1 Tablet 3.06 1156(E) 28.04.2014
1 Tablet 3.18 619(E) 26.02.2015
2.4 Disease modifying agents used in Rheumatoid disorders
(i) Azathioprine Tablets 50 mg 1 Tablet 9.89 1560(E) 14.06.2013
1 Tablet 10.52 1156(E) 28.04.2014
1 Tablet 10.92 619(E) 26.02.2015
(ii) Methotrexate Tablets 5mg 1 Tablet 7.60 1561(E) 14.06.2013
1 Tablet 8.08 1156(E) 28.04.2014
1 Tablet 8.39 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 5 -
Note :

Tablets 7.5mg 1 Tablet 11.27 1562(E) 14.06.2013
1 Tablet 11.98 1156(E) 28.04.2014
1 Tablet 12.44 619(E) 26.02.2015
Tablets 10mg 1 Tablet 13.95 1873(E) 28.06.2013
1 Tablet 14.83 1156(E) 28.04.2014
1 Tablet 15.40 619(E) 26.02.2015
(iii) Sulfasalazine Tablets 500 mg 1 Tablet 3.65 1007(E) 02.04.2014
1 Tablet 3.88 2095(E) 20.08.2014
1 Tablet 4.03 619(E) 26.02.2015
Added medicines
(iv) Hydroxychloroquine Tablets 200 mg 1 Tablet 5.64 1563(E) 14.06.2013
Phosphate 1 Tablet 6.00 1156(E) 28.04.2014
1 Tablet 6.23 619(E) 26.02.2015
(v) Leflunomide Tablets 10mg 1 Tablet 15.10 1874(E) 28.06.2013
1 Tablet 16.05 1156(E) 28.04.2014
1 Tablet 16.67 619(E) 26.02.2015
1 Tablet 30.44 1156(E) 28.04.2014
1 Tablet 31.61 619(E) 26.02.2015
Section: 3 - Antiallergics and Medicines used in Anaphylaxis
(i) Adrenaline Bitartrate Injection 1 mg / ml 1 ml 37.24 1565(E) 14.06.2013
1 ml 39.59 1156(E) 28.04.2014
1 ml 41.11 619(E) 26.02.2015
(ii) Chlorpheniramine Maleate Tablets 4 mg 1 Tablet 0.10 2232(E) 22.07.2013
1 Tablet 0.11 1156(E) 28.04.2014
1 Tablet 0.11423 619(E) 26.02.2015
(iii) Dexchlorpheniramine Syrup 0.5mg /5ml 1 ml 0.30 2831(E) 20.09.2013
Maleate 1 ml 0.32 1156(E) 28.04.2014
1 ml 0.33 619(E) 26.02.2015
(iv) Dexamethasone Tablets 0.5 mg 1 Tablet 0.19 1157(E) 28.04.2014
1 Tablet 0.20 2095(E) 20.08.2014
1 Tablet 0.21 619(E) 26.02.2015
1 ml 2.67 2095(E) 20.08.2014
1 ml 2.77 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 6 -
Note :

(v) Hydrocortisone Sodium Injection 100 mg Each Pack 37.13 2233(E) 22.07.2013
Succinate Each Pack 39.48 1156(E) 28.04.2014
Each Pack 41.00 1156(E) 28.04.2014
(vi) Pheniramine Maleate Injection 22.75 mg / ml 1 ml 1.03 2360(E) 15.09.2014
1 ml 1.07 619(E) 26.02.2015
(vii) Prednisolone Tablets 5 mg 1 Tablet 0.55 1008(E) 02.04.2014
1 Tablet 0.58 2095(E) 28.04.2014
1 Tablet 0.60 619(E) 26.02.2015
1 Tablet 0.98 2095(E) 28.04.2014
1 Tablet 1.02 619(E) 26.02.2015
1 Tablet 1.83 2095(E) 28.04.2014
1 Tablet 1.90 619(E) 26.02.2015
(viii) Promethazine Tablets 10 mg 1 Tablet 0.93 2832(E) 20.09.2013
1 Tablet 0.99 1156(E) 28.04.2014
1 Tablet 1.03 619(E) 26.02.2015
1 Tablet 2.65 1156(E) 28.04.2014
1 Tablet 2.75 619(E) 26.02.2015
Added Medicines
(ix) Cetrizine Tablets 10mg 1 Tablet 1.81 1875(E) 28.06.2013
1 Tablet 1.92 1156(E) 28.04.2014
1 Tablet 1.99 619(E) 26.02.2015
Syrup 5 mg/ml 1 ml 0.54 1876(E) 28.06.2013
1 ml 0.57 1156(E) 28.04.2014
1 ml 0.59 619(E) 26.02.2015
Section: 4 - Antidotes and Other Substances used in Poisonings
4.1: Nonspecific
(i) Activated Charcoal Oral --
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 7 -
Note :

4.2: Specific
(i) Atropine Sulphate Injection 1 mg/ml
(ii) Specific Antisnake venom Injection --
Polyvalent Solution/
Lyophilyzed
Polyvalent Serum
(iii) Calcium Gluconate Injection 100mg/ml 10ml Ampoule 9.95 2868(E) 20.09.2013
10ml Ampoule 10.58 1156(E) 28.04.2014
10ml Ampoule10.99 619(E) 26.02.2015
(iv) Desferrioxamine Mesylate Injection 500mg Each Pack 148.64 3355(E) 05.11.2013
Each Pack 158.03 1156(E) 28.04.2014
Each Pack 164.11 619(E) 26.02.2015
(v) Methylthioninium Chloride Injection 10 mg / ml
(Methylene Blue)
(vi) Penicillamine Tablets or 250 mg 1 Capsule 13.12 1567(E) 14.06.2013
Capsules 1 Capsule 13.95 1156(E) 28.04.2014
1 Capsule 14.49 619(E) 26.02.2015
(vii) Dimercaprol Injection in oil 50 mg / ml
(viii) Flumazenil Injection 0.1 mg / ml
(ix) Sodium Nitrite Injection 30 mg / ml 1 ml 19.83 1783(E) 10.07.2014
1 ml 20.59 619(E) 26.02.2015
(x) Sodium Thiosulphate Injection 250 mg/ ml
(xi) Naloxone Injection 0.4mg/ml 1 ml 91.51 2234(E) 22.07.2013
1 ml 97.29 1156(E) 28.04.2014
1 ml 101.03 619(E) 26.02.2015
(xii) Pralidoxime Chloride Injection 25 mg/ml
(2-PAM)
Added medicines:
(xiii) N-acetylcysteine Injection 200 mg/ml(5 ml) 1 ml 22.52 1568(E) 14.06.2013
1 ml 23.94 1156(E) 28.04.2014
1 ml 24.86 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 8 -
Note :

Section: 5 - Anticonvulsants/ Antiepileptics
(i) Carbamazepine Tablets 100mg 1 Tablet 0.70 1010(E) 02.04.2014
1 Tablet 0.74 2095(E) 20.08.2014
1 Tablet 0.77 619(E) 26.02.2015
1 Tablet 1.46 2095(E) 20.08.2014
1 Tablet 1.52 619(E) 26.02.2015
Syrup 100 mg/5ml 1 ml 0.14 2360(E) 15.09.2014
1 ml 0.15 619(E) 26.02.2015
(ii) Diazepam Injection 5 mg/ml 1 ml 5.59 1549(E) 14.06.2013
1 ml 5.94 1156(E) 28.04.2014
1 ml 6.17 619(E) 26.02.2015
(iii) Magnesium sulphate Injection 500 mg /ml 1 ml 4.96 3328(E) 05.11.2013
1 ml 5.27 1156(E) 28.04.2014
1 ml 5.47 619(E) 26.02.2015
(iv) Phenobarbitone Tablets 30 mg 1 Tablet 0.93 1877(E) 28.06.2013
1 Tablet 0.99 1156(E) 28.04.2014
1 Tablet 1.48 1785(E) 10.07.2014
1 Tablet 1.54 619(E) 26.02.2015
1 Tablet 1.80 1156(E) 28.04.2014
1 Tablet 2.53 1313(E) 19.05.2014
1 Tablet 2.63 619(E) 26.02.2015
Injection 200 mg/ml 1 ml 18.75 2526(E) 21.08.2013
1 ml 19.94 1156(E) 28.04.2014
1 ml 20.71 619(E) 26.02.2015
Syrup 20 mg/5ml 1 ml 0.41 2833(E) 20.09.2013
1 ml 0.44 1156(E) 28.04.2014
1 ml 0.46 619(E) 26.02.2015
(v) Phenytoin Sodium Capsules or 50 mg 1 Tablet 0.77 1570(E) 14.06.2013
Tablets 1 Tablet 0.82 1156(E) 28.04.2014
1 Tablet 0.85 619(E) 26.02.2015
100mg 1 Tablet 1.42 1879(E) 28.06.2013
1 Tablet 1.51 1156(E) 28.04.2014
1 Tablet 1.57 619(E) 26.02.2015
1 Capsule 1.51 1878(E) 28.06.2013
1 Capsule 1.61 1156(E) 28.04.2014
1 Capsule 1.67 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 9 -
Note :

Syrup 25mg/ml
100mg 1ml 0.77 3562(E) 02.12.2013
1ml 0.82 1156(E) 28.04.2014
1ml 0.85 619(E) 26.02.2015
1 ml 5.48 1156(E) 28.04.2014
1 ml 5.69 619(E) 26.02.2015
25mg/ml 1ml 2.31 2089(E) 20.08.2014
1ml 2.40 619(E) 26.02.2015
(vi) Sodium Valproate Tablets 200 mg 1 Tablet 3.07 1571(E) 14.06.2013
1 Tablet 3.26 1156E) 28.04.2014
1 Tablet 3.39 619(E) 26.02.2015
1 Tablet 7.63 1156(E) 28.04.2014
1 Tablet 7.92 619(E) 26.02.2015
Syrup 200 mg/5ml 1 ml 0.58 1572(E) 14.06.2013
1 ml 0.62 1156(E) 28.04.2014
1 ml 0.64 619(E) 26.02.2015
1 ml 5.73 1156(E) 28.04.2014
1 ml 5.95 619(E) 26.02.2015
Added Medicines
(vii) Lorazepam Injection 2mg/ml 1ml 7.39 1573(E) 14.06.2013
1ml 7.86 1156(E) 28.04.2014
1ml 8.16 619(E) 26.02.2015
Section: 6 - Anti-infective Medicines
6.1 Anthelminthics
6.1.1 Intestinal Anthelminthics
(i) Albendazole Tablets 400 mg 1 Tablet 9.12 1793(E) 21.06.2013
1 Tablet 9.70 1156(E) 28.04.2014
1 Tablet 9.92 1790(E) 10.07.2014
1 Tablet 10.30 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 10 -
Note :

Suspension 200 mg/ 5 ml 1 ml 1.48 1794(E) 21.06.2013
1 ml 1.57 1156(E) 28.04.2014
1 ml 1.63 619(E) 26.02.2015
Added Medicines
(ii) Piperazine Tablets 4.5 gm
Solution 750mg/5ml 1 ml 0.28 2834(E) 20.09.2013
1 ml 0.30 1156(E) 28.04.2014
1 ml 0.31 619(E) 26.02.2015
6.1.2Antifilarials
(i) Diethylcarbamazine citrate Tablets 50 mg 1 Tablet 0.47 1574(E) 14.06.2013
1 Tablet 0.50 1156(E) 28.04.2014
1 Tablet 0.52 619(E) 26.02.2015
6.1.3 Antischistosomals and Antitrematode Medicines
(i) Praziquantel Tablets 600 mg 1 Tablet 23.87 3356(E) 05.11.2013
1 Tablet 25.38 1156(E) 28.04.2014
1 Tablet 26.36 619(E) 26.02.2015
6.2 Antibacterials
6.2.1 Beta lactam medicines
(i) Amoxicillin Powder for 125 mg / 5 ml 1 ml 0.57 1795(E) 21.06.2013
suspension 1 ml 0.61 1156(E) 28.04.2014
1 ml 0.63 619(E) 26.02.2015
Capsules 250 mg 1 Capsule 2.76 2046(E) 05.07.2013
1 Capsule 2.93 1156(E) 28.04.2014
1 Capsule 3.04 619(E) 26.02.2015
1 Capsule 6.47 1156(E) 28.04.2014
1 Capsule 6.72 619(E) 26.02.2015
(ii) Ampicillin Capsules 250 mg 1 Capsule 2.50 2047(E) 05.07.2013
1 Capsule 2.66 1156(E) 28.04.2014
1 Capsule 2.76 619(E) 26.02.2015
1 Capsule 5.05 1156(E) 28.04.2014
1 Capsule 5.24 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 11 -
Note :

Powder for 125 mg / 5 ml 1 ml 0.63 1575(E) 14.06.2013
suspension 1 ml 0.67 1156(E) 28.04.2014
1 ml 0.70 619(E) 26.02.2015
Injection 500 mg Each Pack 13.40 1798(E) 21.06.2013
Each Pack 14.25 1156(E) 28.04.2014
Each Pack 14.80 619(E) 26.02.2015
(iii) Benzathine Benzylpenicillin Injection 6 lacs units 1 Injection 7.61 1011(E) 02.04.2014
1 ml 8.09 2095(E) 20.08.2014
1 ml 8.40 619(E) 26.02.2015
Injection 12 lacs units 1 Injection 11.07 948(E) 27.03.2014
1 ml 11.77 2095(E) 20.08.2014
1 ml 12.22 619(E) 26.02.2015
(iv) Cefotaxime Injection 125 mg Each Pack 12.84 2093(E) 20.08.2014
Each Pack 13.33 619(E) 26.02.2015
Each Pack 15.77 619(E) 26.02.2015
Each Pack 20.82 619(E) 26.02.2015
(v) Ceftazidime Injection 250mg Each Pack 63.40 1576(E) 14.06.2013
Each Pack 67.41 1156(E) 28.04.2014
Each Pack 70.00 619(E) 26.02.2015
Injection 1gm Each Pack 229.19 1799(E) 21.06.2013
Each Pack 243.67 1156(E) 28.04.2014
Each Pack 253.05 619(E) 26.02.2015
(vi) Ceftriaxone Injection 250mg Each Pack 24.60 1800(E) 21.06.2013
Each Pack 26.15 1156(E) 28.04.2014
Each Pack 27.16 619(E) 26.02.2015
Injection 1gm Each Pack 55.44 2235(E) 22.07.2013
Each Pack 58.94 1156(E) 28.04.2014
Each Pack 61.21 619(E) 26.02.2015
(vii) Cephalexin Syrup 125 mg / 5 ml 1 ml 0.91 2050(E) 05.07.2013
1 ml 0.97 1156(E) 28.04.2014
1 ml 1.01 619(E) 26.02.2015
1 Capsule 5.58 1156(E) 28.04.2014
1 Capsule 5.79 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 12 -
Note :

1 Capsule 12.39 1156(E) 28.04.2014
1 Capsule 12.87 619(E) 26.02.2015
(viii) Cloxacillin Capsules 250 mg 1 Capsule 1.29 3127(E) 10.12.2014
1 Capsule 1.34 619(E) 26.02.2015
1 Capsule 2.30 619(E) 26.02.2015
Each Pack 3.86 619(E) 26.02.2015
Liquid 125mg/ 5 ml
Added Medicines
(ix) Amoxicillin+Clavulinic acid Tablets 625 mg 1 Tablet 22.46 1881(E) 28.06.2013
1 Tablet 23.88 1156(E) 28.04.2014
1 Tablet 24.80 619(E) 26.02.2015
Powder for 228.5mg/5ml 1 ml 1.87 1882(E) 28.06.2013
suspension 1 gm 1.99 1156(E) 28.04.2014
suspension 1 gm 2.07 619(E) 26.02.2015
Injection 600mg Each pack 85.96 1883(E) 28.06.2013
Each pack 91.39 1156(E) 28.04.2014
Each pack 94.91 619(E) 26.02.2015
Injection 1.2gm Each pack 127.37 1884(E) 28.06.2013
Each pack 135.42 1156(E) 28.04.2014
Each pack 140.63 619(E) 26.02.2015
(x) Cefixime Tablet 100 mg 1 Tablet 7.69 1820(E) 21.06.2013
1 Tablet 8.18 1156(E) 28.04.2014
1 Tablet 8.49 619(E) 26.02.2015
Tablet 200mg 1 Tablet 11.25 2236(E) 22.07.2013
1 Tablet 11.96 1156(E) 28.04.2014
1 Tablet 12.42 619(E) 26.02.2015
6.2.2 Other antibacterials
(i) Amikacin Injection 250 mg / 2 ml 1 ml 13.96 1801(E) 21.06.2013
1 ml 14.84 1156(E) 28.04.2014
1 ml 15.41 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 13 -
Note :

(ii) Azithromycin Tablets 100mg 1 Tablet 5.13 2051(E) 05.07.2013
1 Tablet 5.45 1156(E) 28.04.2014
1 Tablet 5.66 619(E) 26.02.2015
1 Tablet 10.91 1156(E) 28.04.2014
1 Tablet 11.33 619(E) 26.02.2015
1 Tablet 20.51 3379(E) 05.11.2013
1 Tablet 21.81 1156(E) 28.04.2014
1 Tablet 22.65 619(E) 26.02.2015
Suspension 100mg/5ml 1 ml 1.55 2237(E) 22.07.2013
1 ml 1.65 1156(E) 28.04.2014
1 ml 1.71 619(E) 26.02.2015
Injection 500mg Each Pack 182.27 1578(E) 14.06.2013
Each Pack 193.79` 1156(E) 28.04.2014
Each Pack 201.25 619(E) 26.02.2015
(iii) Ciprofloxacin Hydrochloride Injection 200 mg /100 ml 1 ml 0.16 1157 (E) 28.04.2014
1 ml 0.27 1784 (E) 10.07.2014
S.O. No. 1784(E) dt 10.07.2014 withdraw with immediate effect 1823(E) 11.07.2014
1ml 0.17 2095(E) 20.08.2014
1ml 0.18 619(E) 26.02.2015
1 Tablet 2.10 619(E) 26.02.2015
1 Tablet 4.01 619(E) 26.02.2015
(iv) Co-Trimoxazole Tablets 80 + 400 mg 1 Tablet 0.58 2360(E) 15.09.2014
(Trimethoprim + 1 Tablet 0.60 619(E) 26.02.2015
Sulphamethoxazole)
Tablets 160+800 mg 1 Tablet 1.28 1157(E) 28.04.2014
1 Tablet 1.36 2095(E) 20.08.2014
1 Tablet 1.32 3133(E) 10.12.2014
1 Tablet 1.37 619(E) 26.02.2015
Suspension 40+200 mg/5 ml 1 ml 0.24 1157(E) 28.04.2014
1 ml 0.26 2095(E) 20.08.2014
1 ml 0.27 619(E) 26.02.2015
(v) Doxycycline Tablets 100 mg 1 Tablet 0.94 1157(E) 28.04.2014
1 Tablet 1.00 2095(E) 20.08.2014
1 Tablet 1.04 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 14 -
Note :

(vi) Erythromycin Estolate Syrup 125 mg / 5 ml
Tablets 250 mg
Tablets 500 mg
(v) Gentamicin Injection 10 mg/ml 1ml 3.18 3127(E) 10.12.2014
1ml 3.30 619(E) 26.02.2015
1 ml 2.32 2095(E) 20.08.2014
1 ml 2.41 619(E) 26.02.2015
(vi) Metronidazole Tablet 200mg
Tablet 400mg
Injection 500mg/100ml
Syrup 100mg/5ml 1 ml 0.16 1012(E) 02.04.2014
1 ml 0.17 2095(E) 20.08.2014
1 ml 0.18 619(E) 26.02.2015
(vii) Nitrofurantoin Tablets 100 mg 1 Tablet 6.88 1885(E) 28.06.2013
1 Tablet 7.31 1156(E) 28.04.2014
1 Tablet 7.59 619(E) 26.02.2015
(viii) Sulphadiazine Tablets 500 mg 1 Tablet 0.83 2360(E) 15.09.2014
1 Tablet 0.86 619(E) 26.02.2015
(ix) Vancomycin Hydrochloride Injection 500 mg Each Pack 330.60 1579(E) 14.06.2013
Each Pack 351.49 1156(E) 28.04.2014
Each Pack 365.02 619(E) 26.02.2015
Injection 1 gm Each Pack 514.44 1580(E) 14.06.2013
Each Pack 546.95 1156(E) 28.04.2014
Each Pack 568.00 619(E) 26.02.2015
6.2.3 Antileprosy medicines
(i) Clofazimine Capsules 50 mg 1 Capsule 1.28 1581(E) 14.06.2013
1 Capsule 1.36 1156(E) 28.04.2014
1 Capsule 1.41 619(E) 26.02.2015
1 Capsule 2.36 1156(E) 28.04.2014
1 Capsule 2.45 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 15 -
Note :

(ii) Dapsone Tablets 50 mg 1 Tablet 0.20 2835(E) 20.09.2013
1 Tablet 0.21 1156(E) 28.04.2014
1 Tablet 0.22 619(E) 26.02.2015
1 Tablet 0.23 1156(E) 28.04.2014
1 Tablet 0.24 619(E) 26.02.2015
(iii) Rifampicin Capsules or 150 mg 1 Tablet 1.22 2360(E) 15.09.2014
Tablets 1 Tablet 1.27 619(E) 26.02.2015
Capsules or 300 mg 1 Tablet 2.76 2354(E) 15.09.2014
Tablets 1 Tablet 2.87 619(E) 26.02.2015
6.2.4 Antituberculosis medicines
(i) Ethambutol Tablets 200 mg 1 Tablet 0.97 2837(E) 20.09.2013
1 Tablet 1.03 1156(E) 28.04.2014
1 Tablet 1.07 619(E) 26.02.2015
1 Tablet 2.31 1156(E) 28.04.2014
1 Tablet 2.40 619(E) 26.02.2015
1 Tablet 3.35 1156(E) 28.04.2014
1 Tablet 3.48 619(E) 26.02.2015
1 Tablet 3.98 1156(E) 28.04.2014
1 Tablet 4.13 619(E) 26.02.2015
(ii) Isoniazid Tablets 50 mg
1 Tablet 0.77 1156(E) 28.04.2014
1 Tablet 0.80 619(E) 26.02.2015
1 Tablet 1.35 1156(E) 28.04.2014
1 Tablet 1.40 619(E) 26.02.2015
Syrup 100 mg/5ml 1 ml 0.22 3357(E) 05.11.2013
1 ml 0.23 1156(E) 28.04.2014
1 ml 0.24 619(E) 26.02.2015
(iii) Ofloxacin Tablets 100 mg 1 Tablet 3.30 2053(E) 05.07.2013
1 Tablet 3.51 1156(E) 28.04.2014
1 Tablet 3.65 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 16 -
Note :

1 Tablet 5.21 1156(E) 28.04.2014
1 Tablet 5.41 619(E) 26.02.2015
Syrup 50 mg / 5 ml 1 ml 0.67 1586(E) 14.06.2013
1 ml 0.71 1156(E) 28.04.2014
1 ml 0.74 619(E) 26.02.2015
(iv) Pyrazinamide Tablets 500 mg 1 Tablet 3.77 1587(E) 14.06.2013
1 Tablet 4.01 1156(E) 28.04.2014
1 Tablet 4.16 619(E) 26.02.2015
1 Tablet 7.35 1156(E) 28.04.2014
1 Tablet 7.63 619(E) 26.02.2015
1 Tablet 8.82 1156(E) 28.04.2014
1 Tablet 9.16 619(E) 26.02.2015
1 Tablet 10.40 1156(E) 28.04.2014
1 Tablet 10.80 619(E) 26.02.2015
(v) Rifampicin Capsules/Tablets 50 mg
Capsules/Tablets 150 mg 1 Tablet 1.22 2360(E) 15.09.2014
1 Tablet 1.27 619(E) 26.02.2015
1 Tablet 2.87 619(E) 26.02.2015
1 Tablet 4.22 619(E) 26.02.2015
Syrup 100 mg / 5 ml
(vi) Streptomycin Sulphate Injection 0.75 gm Each Pack 7.91 1157(E) 28.04.2014
1ml 8.41 2095(E) 20.08.2014
1ml 8.73 619(E) 26.02.2015
1 gm 1 Injection 9.67 949(E) 27.03.2014
1ml 10.28 2095(E) 20.08.2014
1ml 10.68 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 17 -
Note :

6.3 Antifungal medicines
(i) Amphotericin B Injection 50 mg Each Pack 4245.32 1912(E) 28.06.2013
Each Pack 4513.62 1156(E) 28.04.2014
Each Pack 4687.35 619(E) 26.02.2015
(ii) Clotrimazole Pessaries 100 mg 1 Pessaries 8.47 3330(E) 05.11.2013
1 Pessaries 8.69 423(E) 17.02.2014
1 Pessaries 9.24 1156(E) 28.04.2014
1 Pessaries 9.60 619(E) 26.02.2015
Pessaries 200 mg 1 Pessaries 12.71 3358(E) 05.11.2013
1 Pessaries 13.31 922(E) 27.03.2014
1 Pessaries 14.15 1156(E) 28.04.2014
1 Pessaries 14.69 619(E) 26.02.2015
Gel 2% 1 gm 2.07 1886(E) 28.06.2013
1 gm 2.20 1156(E) 28.04.2014
1 gm 2.28 619(E) 26.02.2015
(iii) Fluconazole Capsules or 50 mg 1 Capsule 10.16 1822(E) 21.06.2013
Tablets 1 Capsule 10.80 1156(E) 28.04.2014
1 Tablet 7.83 1823(E) 21.06.2013
1 Tablet 8.32 1156(E) 28.04.2014
1 Tablet 8.64 619(E) 26.02.2015
Capsules or 100 mg 1 Capsule 23.81 2849(E) 20.09.2013
1 Capsule 26.28 619(E) 26.02.2015
1 Tablet 14.16 1824(E) 21.6.2013
1 Tablet 15.05 1156(E) 28.04.2014
1 Tablet 15.63 619(E) 26.02.2015
1 Capsule 26.05 619(E) 26.02.2015
1 Tablet 14.45 2055(E) 05.07.2013
1 Tablet 15.36 1156(E) 28.04.2014
1 Tablet 15.95 619(E) 26.02.2015
1 Capsule 42.96 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 18 -
Note :

1 Tablet 25.86 1826(E) 21.06.2013
1 Tablet 27.49 1156(E) 28.04.2014
1 Tablet 28.55 619(E) 26.02.2015
(iv) Griseofulvin Capsules or 125 mg 1 Tablet 0.75 3127(E) 10.12.2014
Tablets 1 Tablet 0.78 619(E) 26.02.2015
Capsules or 250 mg 1 Tablet 1.45 1157(E) 28.04.2014
Tablets 1 Tablet 1.60 619(E) 26.02.2015
(v) Nystatin Tablets 500,000 IU
Pessaries 100,000 IU
6.4 Antiviral medicines
6.4.1 Antiherpes medicines
(i) Acyclovir Tablets 200 mg 1 Tablet 7.30 1590(E) 14.06.2013
1 Tablet 7.76 1156(E) 28.04.2014
1 Tablet 8.06 619(E) 26.02.2015
1 Tablet 12.38 1156(E) 28.04.2014
1 Tablet 12.86 619(E) 26.02.2015
Each Pack 489.13 1156(E) 28.04.2014
Each Pack 507.96 619(E) 26.02.2015
Each Pack 461.23 1156(E) 28.04.2014
Each Pack 478.98 619(E) 26.02.2015
Suspension 400 mg / 5 ml 1 ml 1.32 2839(E) 20.09.2013
1 ml 1.40 1156(E) 28.04.2014
1 ml 1.45 619(E) 26.02.2015
6.4.2 Antiretroviral medicines
6.4.2.1 Nucleoside reverse transcriptase inhibitors
(i) Didanosine Tablets 250 mg 1 Tablet 23.93 2840(E) 20.09.2013
1 Tablet 25.44 1156(E) 28.04.2014
1 Tablet 26.42 619(E) 26.02.2015
1 Tablet 34.09 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 19 -
Note :

(ii) Lamivudine Tablets 150 mg 1 Tablet 9.40 1888(E) 28.06.2013
1 Tablet 9.99 1156(E) 28.04.2014
1 Tablet 10.37 619(E) 26.02.2015
(iii) Lamivudine + Nevirapine Tablets 150 mg+200 mg 1 Tablet 17.29 1591(E) 14.06.2013
+ Stavudine + 30 mg 1 Tablet 18.38 1156(E) 28.04.2014
1 Tablet 19.09 619(E) 26.02.2015
(iv) Lamivudine + Zidovudine Tablets 150 mg+300 mg 1 Tablet 19.63 1592(E) 14.06.2013
1 Tablet 20.87 1156(E) 28.04.2014
1 Tablet 21.67 619(E) 26.02.2015
(v) Stavudine Capsules 15 mg
1 Capsule 2.92 1156(E) 28.04.2014
1 Capsule 3.03 619(E) 26.02.2015
1 Capsule 3.32 1156(E) 28.04.2014
1 Capsule 3.45 619(E) 26.02.2015
(vi) Zidovudine Tablets 100 mg
1 Tablet 15.92 1156(E) 28.04.2014
1 Tablet 16.53 619(E) 26.02.2015
ADDED MEDICINES
(vii) Stavudine+Lamivudine Tablets 30mg+150mg 1 Tablet 9.20 1593(E) 14.06.2013
1 Tablet 9.78 1156(E) 28.04.2014
1 Tablet 10.16 619(E) 26.02.2015
(viii) Zidovudine+Lamivudine+ Tablets 300mg+150mg+ 1 Tablet 19.05 1594(E) 14.06.2013
Nevirapine 200mg 1 Tablet 20.25 1156(E) 28.04.2014
1 Tablet 21.03 619(E) 26.02.2015
6.4.2.2 Non-nucleoside reverse transcriptase inhibitors
(i) Efavirenz Capsules 200 mg 1 Capsule 23.16 3359(E) 05.11.2013
1 Capsule 24.62 1156(E) 28.04.2014
1 Capsule 25.57 619(E) 26.02.2015
1 Capsule 61.79 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 20 -
Note :

(ii) Nevirapine Capsules 200 mg
Suspension 50 mg / 5 ml 1 ml 0.98 1595(E) 14.06.2013
1 ml 1.04 1156(E) 28.04.2014
1 ml 1.08 619(E) 26.02.2015
6.4.2.3 Protease inhibitors
(i) Indinavir Capsules 200 mg
1 Capsule 20.64 1156(E) 28.04.2014
1 Capsule 21.43 619(E) 26.02.2015
(ii) Nelfinavir Capsules 250 mg
(iii) Ritonavir Capsules 100 mg 1 Capsule 34.22 3360(E) 05.11.2013
1 Capsule 36.38 1156(E) 28.04.2014
1 Capsule 37.78 619(E) 26.02.2015
Syrup 400 mg / 5ml
(iv) Saquinavir Capsules 200 mg
6.5 Antiprotozoal Medicines
6.5.1 Antiamoebic and Antigiardiasis medicines
(i) Diloxanide Furoate Tablets 500 mg 1 Tablet 1.61 3361(E) 05.11.2013
1 Tablet 1.71 1156(E) 28.04.2014
1 Tablet 1.78 619(E) 26.02.2015
(ii) Metronidazole Tablets 200 mg
Tablets 400 mg
Injection 500 mg /100 ml
6.5.2 Antileishmaniasis medicines
(i) Amphotericin B Injection 50 mg Each Pack 4245.32 1912(E) 28.06.2013
Each Pack 4513.62 1156(E) 28.04.2014
Each Pack 4687.35 619(E) 26.02.2015
(ii) Pentamidine Isothionate Injection 200 mg
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 21 -
Note :

(iii) Sodium Stibogluconate Injection 100 mg / ml 1 ml 3.26 3362(E) 05.11.2013
1 ml 3.47 1156(E) 28.04.2014
1 ml 3.60 619(E) 26.02.2015
6.5.3 Antimalarial Medicines
6.5.3.1 For curative treatment
(i) Artesunate (To be used Tablets 50 mg 1 Tablet 20.04 1802(E) 21.06.2013
only in combination with 1 Tablet 21.31 1156(E) 28.04.2014
Sulfadoxine + 1 Tablet 22.13 619(E) 26.02.2015
Pyrimethamine)
(ii) Chloroquine phosphate Tablets 150 mg base
Injection 40 mg / ml
Syrup 50 mg / 5 ml
(iii) Primaquine Tablets 2.5 mg 1 Tablet 1.55 1821(E) 21.06.2013
1 Tablet 1.65 1156(E) 28.04.2014
1 Tablet 1.71 619(E) 26.02.2015
Tablets 7.5 mg 1 Tablet 1.98 1597(E) 14.06.2013
1 Tablet 2.11 1156(E) 28.04.2014
1 Tablet 2.19 619(E) 26.02.2015
(iv) Pyrimethamine Tablets 25 mg 1 Tablet 0.89 1780(E) 10.07.2014
1 Tablet 0.92 619(E) 26.02.2015
(v) Quinine sulphate Tablets 300 mg 1 Tablet 5.10 1598(E) 14.06.2013
1 Tablet 5.42 1156(E) 28.04.2014
1 Tablet 5.63 619(E) 26.02.2015
Injection 300 mg / ml 1ml 9.07 1599(E) 14.06.2013
1ml 9.64 1156(E) 28.04.2014
1ml 10.01 619(E) 26.02.2015
(vi) Sulfadoxine + Tablets 500 mg+ 1 Tablet 1.96 1013(E) 02.04.2014
Pyrimethamine 25 mg 1 Tablet 2.08 2095(E) 20.08.2014
1 Tablet 2.16 619(E) 26.02.2015
Medicines added
(vii) Clindamycin Tablet 150mg
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 22 -
Note :

Tablet 300mg 1 Tablet 13.09 3332(E) 05.11.2013
1 Tablet 13.92 1156(E) 28.04.2014
1 Tablet 14.46 619(E) 26.02.2015
6.5.3.2 For prophylaxis
Medicines added
(i) Mefloquine Tablet 250 mg base 1 Tablet 50.06 1600(E) 14.06.2013
1 Tablet 53.22 1156(E) 28.04.2014
1 Tablet 55.27 619(E) 26.02.2015
6.5.4 Antipneumocystosis and Antitoxoplasmosis medicines
(i) Co-Trimoxazole Tablets 80 + 400 mg 1 Tablet 0.58 2360(E) 15.09.2014
(Trimethoprim + 1 Tablet 0.60 619(E) 26.02.2015
Sulphamethoxazole)
Tablets 160+800 mg 1 Tablet 1.28 1157(E) 28.04.2014
1 Tablet 1.36 2095(E) 20.08.2014
1 Tablet 1.32 3133(E) 10.12.2014
1 Tablet 1.37 619(E) 26.02.2015
Suspension 40+200mg/5 ml 1 ml 0.24 1157(E) 28.04.2014
1 ml 0.26 2095(E) 20.08.2014
1 ml 0.27 619(E) 26.02.2015
(ii) Pentamidine Isothionate Injection 200 mg
Section: 7 -Antimigraine medicines
7.1: For treatment of acute attack
(i) Acetyl Salicylic Acid Tablets 300 - 350 mg
325mg 1 Tablet 0.44 2360(E) 15.09.2014
1 Tablet 0.46 619(E) 26.02.2015
(ii) Dihydroergotamine Tablets 1 mg 1 Tablet 16.71 1601(E) 14.06.2013
1 Tablet 17.77 1156(E) 28.04.2014
1 Tablet 18.45 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 23 -
Note :

(iii) Paracetamol Tablets 500 mg 1 Tablet 0.94 1555(E) 14.06.2013
1 Tablet 1.00 1156(E) 28.04.2014
1 Tablet 1.04 619(E) 26.02.2015
7.2: For Prophylaxis
(i) Propranolol Hydrochloride Tablets 10 mg 1 Tablet 1.09 2240(E) 22.07.2013
1 Tablet 1.16 1156(E) 28.04.2014
1 Tablet 1.20 619(E) 26.02.2015
40 mg 1Tablet 2.56 2528(E) 21.08.2013
1 Tablet 2.72 1156(E) 28.04.2014
1 Tablet 2.82 619(E) 26.02.2015
Section: 8 - Antineoplastic, immunosuppressives and medicines used in palliative care
8.1: Immunosuppressive medicines
(i) Azathioprine Tablets 50 mg 1 Tablet 9.89 1560(E) 14.06.2013
1 Tablet 10.52 1156(E) 28.04.2014
1 Tablet 10.92 619(E) 26.02.2015
(ii) Cyclosporine Capsules 10 mg
1 Capsule 26.31 1156(E) 28.04.2014
1 Capsule 27.32 619(E) 26.02.2015
1 Capsule 51.31 1156(E) 28.04.2014
1 Capsule 53.28 619(E) 26.02.2015
1 Capsule 113.01 1156(E) 28.04.2014
1 Capsule 117.36 619(E) 26.02.2015
Concentrate for 100 mg/ml 1 ml 118.64 3333(E) 05.11.2013
Injection 1 ml 126.14 1156(E) 28.04.2014
1 ml 131.00 619(E) 26.02.2015
8.2: Cytotoxic medicines
(i) Actinomycin D Injection 0.5 mg 1 Injection 562.98 1781(E) 10.07.2014
1 Injection 584.65 619(E) 26.02.2015
(ii) Alpha Interferon Injection 3 million IU Each Pack 759.70 1604(E) 14.06.2013
Each Pack 807.71 1156(E) 28.04.2014
Each Pack 838.80 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 24 -
Note :

(iii) Bleomycin Injection 15 mg 1 ml 616.06 1605(E) 14.06.2013
1 ml 654.99 1156(E) 28.04.2014
1 ml 680.20 619(E) 26.02.2015
(iv) Busulphan Tablets 2 mg 1 Tablet 3.41 3363(E) 05.11.2013
1 Tablet 3.63 1156(E) 28.04.2014
1 Tablet 3.77 619(E) 26.02.2015
(v) Cisplatin Injection 10 mg / vial Each Pack 84.84 2241(E) 22.07.2013
Each Pack 90.20 1156(E) 28.04.2014
Each Pack 93.67 619(E) 26.02.2015
Injection 50 mg / vial Each Pack 301.26 1890(E) 28.06.2013
Each Pack 320.30 1156(E) 28.04.2014
Each Pack 332.63 619(E) 26.02.2015
(vi) Cyclophosphamide Tablets 50 mg 1 Tablet 3.75 1606(E) 14.06.2013
1 Tablet 3.99 1156(E) 28.04.2014
1 Tablet 4.14 619(E) 26.02.2015
Tablets 200 mg
Injection 500 mg 1 Injectable 72.71 2529(E) 21.08.2013
1 Injectable 77.31 1156(E) 28.04.2014
1 Injectable 80.29 619(E) 26.02.2015
(vii) Cytosine arabinoside Injection 100 mg/vial Each Pack 238.44 1914(E) 28.06.2013
Each Pack 253.51 1156(E) 28.04.2014
Each Pack 263.27 619(E) 26.02.2015
Injection 500 mg/vial Each Pack 515.53 1891(E) 28.06.2013
Each Pack 548.11 1156(E) 28.04.2014
Each Pack 569.21 619(E) 26.02.2015
Injection 1000 mg/vial Each Pack 1170.62 1892(E) 28.06.2013
Each Pack 1244.60 1156(E) 28.04.2014
Each Pack 1292.50 619(E) 26.02.2015
(viii) Danazol Capsules 50 mg 1 Capsule 9.37 1607(E) 14.06.2013
1 Capsule 9.96 1156(E) 28.04.2014
1 Capsule 10.34 619(E) 26.02.2015
1 Capsule 21.61 1156(E) 28.04.2014
1 Capsule 22.44 619(E) 26.02.2015
(ix) Doxorubicin Injection 10 mg Each Pack 196.48 1893(E) 28.06.2013
Each Pack 208.90 1156(E) 28.04.2014
Each Pack 216.94 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 25 -
Note :

50 mg Each Pack 1145.20 1609(E) 14.06.2013
Each Pack 1217.58 1156(E) 28.04.2014
Each Pack 1264.44 619(E) 26.02.2015
(x) Etoposide Capsules 100 mg 1 Capsule 52.30 3364(E) 05.11.2013
1 Capsule 55.61 1156(E) 28.04.2014
1 Capsule 57.75 619(E) 26.02.2015
Injection 100mg/5ml vial Each Pack 192.39 1915(E) 28.06.2013
Each Pack 204.55 1156(E) 28.04.2014
Each Pack 212.42 619(E) 26.02.2015
(xi) Flutamide Tablet 250 mg 1 Tablet 8.62 1894(E) 28.06.2013
1 Tablet 9.16 1156(E) 28.04.2014
1 Tablet 9.51 619(E) 26.02.2015
(xii) 5-Fluorouracil Injection 250 mg / 5 ml 1 ml 2.08 3556(E) 02.12.2013
1 ml 2.21 1156(E) 28.04.2014
1 ml 2.30 619(E) 26.02.2015
(xiii) Folinic Acid Injection 3 mg / ml
(xiv) Gemcitabine hydrochloride Injection 200 mg Each Pack 1304.86 1610(E) 14.06.2013
Each Pack 1387.33 1156(E) 28.04.2014
Each Pack 1440.73 619(E) 26.02.2015
Injection 1 gm Each Pack 5969.16 1611(E) 14.06.2013
Each Pack 6346.41 1156(E) 28.04.2014
Each Pack 6590.68 619(E) 26.02.2015
(xv) L- Asparaginase Injection 5000 KU. Each Pack 1183.92 3334(E) 05.11.2013
Each Pack 1258.74 1156(E) 28.04.2014
Each Pack 1307.19 619(E) 26.02.2015
(xvi) Melphalan Tablet 2 mg 1 Tablet 108.53 3335(E) 05.11.2013
1 Tablet 115.39 1156(E) 28.04.2014
1 Tablet 119.83 619(E) 26.02.2015
Tablet 5 mg 1 Tablet 182.06 3336(E) 05.11.2013
1 Tablet 193.57 1156(E) 28.04.2014
1 Tablet 201.02 619(E) 26.02.2015
(xvii) Mercaptopurine Tablet 50 mg 1 Tablet 8.93 3337(E) 05.11.2013
1 Tablet 9.49 1156(E) 28.04.2014
1 Tablet 9.86 619(E) 26.02.2015
Injection 100 mg / ml
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 26 -
Note :

(xviii) Methotrexate Tablet 2.5 mg 1 Tablet 4.72 1612(E) 14.06.2013
1 Tablet 5.02 1156(E) 28.04.2014
1 Tablet 5.21 619(E) 26.02.2015
1 ml 35.28 1156(E) 28.04.2014
1 ml 36.64 619(E) 26.02.2015
(xix) Mitomycin-C Injection 10 mg Each Pack 397.57 3557(E) 02.12.2013
Each Pack 422.70 1156(E) 28.04.2014
Each Pack 438.97 619(E) 26.02.2015
(xx) Paclitaxel Injection 30 mg / 5 ml Each Pack 301.24 3338(E) 05.11.2013
Each Pack 320.28 1156(E) 28.04.2014
Each Pack 332.61 619(E) 26.02.2015
(xxi) Procarbazine Capsules 50 mg 1 Capsule 31.64 3339(E) 05.11.2013
1 Capsule 33.64 1156(E) 28.04.2014
1 Capsule 34.93 619(E) 26.02.2015
(xxii) Vinblastine Sulphate Injection 10 mg Each Pack 284.90 3340(E) 05.11.2013
Each Pack 302.91 1156(E) 28.04.2014
Each Pack 314.57 619(E) 26.02.2015
(xxiii) Vincristine Injection 1 mg / ml Each Pack 50.60 1613(E) 14.06.2013
Each Pack 53.80 1156(E) 28.04.2014
Each Pack 55.87 619(E) 26.02.2015
Added medicines
(xxiv) Carboplatin Injection 150 mg vial Each Pack 789.01 1895(E) 28.06.2013
Each Pack 838.88 1156(E) 28.04.2014
Each Pack 871.17 619(E) 26.02.2015
Injection 450 mg vial Each Pack 2424.93 1916(E) 28.06.2013
Each Pack 2578.19 1156(E) 28.04.2014
Each Pack 2677.42 619(E) 26.02.2015
(xv) Dacarbazine Injection 500 mg Each Pack 1029.09 1614(E) 14.06.2013
Each Pack 1094.13 1156(E) 28.04.2014
Each Pack 1136.24 619(E) 26.02.2015
(xvi) Daunorubicin Injection 20 mg vial Each Pack 353.69 3341(E) 05.11.2013
Each Pack 376.04 1156(E) 28.04.2014
Each Pack 390.51 619(E) 26.02.2015
(xvii) Ifosfamide Injection 1 gm/2ml vial Each Pack 344.88 3558(E) 02.12.2013
Corrigendum reg. S.O. No. 3558(E) dt. 2.12.2013 430(E) 17.02.2014
Each Pack 366.68 1156(E) 28.04.2014
Each Pack 380.79 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 27 -
Note :

(xviii) Mesna Injection 200 mg 1 ml 24.57 2243(E) 22.07.2013
1 ml 26.12 1156(E) 28.04.2014
1 ml 27.13 619(E) 26.02.2015
(xix) Oxaliplatin Injection 50 mg vial 1 Injectable 2993.26 2530(E) 21.08.2013
1 Injectable 3182.43 1156(E) 28.04.2014
1 Injectable 3304.92 619(E) 26.02.2015
(xx) Imatinib Tablets 100 mg 1 Tablet 87.59 1827(E) 21.06.2013
1 Tablet 93.13 1156(E) 28.04.2014
1 Tablet 96.71 619(E) 26.02.2015
1 Tablet 285.29 1156(E) 28.04.2014
1 Tablet 296.27 619(E) 26.02.2015
(xxi) Chlorambucil Tablets 2 mg 1 Tablet 45.22 3342(E) 05.11.2013
1 Tablet 48.08 1156(E) 28.04.2014
1 Tablet 49.93 619(E) 26.02.2015
8.3: Hormones and antihormones
(i) Prednisolone Tablets 5 mg 1 Tablet 0.55 1008(E) 02.04.2014
1 Tablet 0.58 2095(E) 20.08.2014
1 Tablet 0.60 619(E) 26.02.2015
Injection 20 mg (as 1 ml 4.41 2360(E) 15.09.2014
sodium 1 ml 4.58 619(E) 26.02.2015
phosphate or
succinate)
Injection 25 mg (as
sodium
phosphate or
succinate)
(ii) Raloxifene Tablets 60 mg 1 Tablet 9.89 1616(E) 14.06.2013
1 Tablet 10.52 1156(E) 28.04.2014
1 Tablet 10.92 619(E) 26.02.2015
(iii) Tamoxifen Citrate Tablets 10 mg 1 Tablet 4.35 1896(E) 28.06.2013
1 Tablet 4.62 1156(E) 28.04.2014
1 Tablet 4.80 619(E) 26.02.2015
1 Tablet 2.95 1156(E) 28.04.2014
1 Tablet 3.06 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 28 -
Note :

8.4: Medicines used in palliative care
(i) Morphine Sulphate Tablets 10 mg 1 Tablet 5.04 2857(E) 20.09.2013
1 Tablet 5.36 1156(E) 28.04.2014
1 Tablet 5.57 619(E) 26.02.2015
(ii) Ondansetron Tablets 4 mg 1 Tablet 4.76 2244(E) 22.07.2013
1 Tablet 5.06 1156(E) 28.04.2014
1 Tablet 5.25 619(E) 26.02.2015
1 Tablet 11.77 1156(E) 28.04.2014
1 Tablet 12.22 619(E) 26.02.2015
1 ml 7.84 1156(E) 28.04.2014
1 ml 8.14 619(E) 26.02.2015
Syrup 2 mg/5 ml 1 ml 1.04 1804(E) 21.06.2013
1 ml 1.11 1156(E) 28.04.2014
1 ml 1.15 619(E) 26.02.2015
Added Medicines
(iii) Filgrastim Injection 1 ml vial 1ml 2142.79 1897(E) 28.06.2013
1ml 2278.21 1156(E) 28.04.2014
1ml 2365.90 619(E) 26.02.2015
(iv) Allopurinol Tablets 100 mg 1 Tablet 2.09 2830(E) 20.09.2013
1 Tablet 2.22 1156(E) 28.04.2014
1 Tablet 2.31 619(E) 26.02.2015
Section: 9 -Antiparkinsonism medicines
(i) Bromocriptine Mesylate Tablets 1.25 mg 1 Tablet 7.58 1805(E) 21.06.2013
1 Tablet 8.06 1156(E) 28.04.2014
1 Tablet 8.37 619(E) 26.02.2015
Tablets 2.5 mg 1 Tablet 13.60 1806(E) 21.06.2013
1 Tablet 14.46 1156(E) 28.04.2014
1 Tablet 15.02 619(E) 26.02.2015
(ii) Levodopa+ Carbidopa Tablets 100 mg+10 mg 1 Tablet 1.44 950(E) 27.03.2014
1 Tablet 1.61 2095(E) 20.08.2014
1 Tablet 1.67 619(E) 26.02.2015
Tablets 250 mg+25 mg 1 Tablet 3.46 951(E) 27.03.2014
1 Tablet 3.85 2095(E) 20.08.2014
1 Tablet 4.00 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 29 -
Note :

Tablets 100 mg+25 mg 1 Tablet 2.00 1014(E) 02.04.2014
1 Tablet 2.26 2095(E) 20.08.2014
1 Tablet 2.35 619(E) 26.02.2015
(iii) Trihexyphenidyl Tablets 2 mg 1 Tablet 1.36 1619(E) 14.06.2013
Hydrochloride 1 Tablet 1.45 1156(E) 28.04.2014
1 Tablet 1.51 619(E) 26.02.2015
Section: 10 -Medicines affecting the blood
10.1: Antianaemia medicines
(i) Cyanocobalamin Injection 1 mg/ml
(ii) Ferrous Sulphate/ Fumrate Tablets Tablets
equivalent to
60 mg elemental
iron
Oral solution 25mg elemental
iron (as
sulphate)/ml
(iii) Folic Acid Tablets 1 mg 1 Tablet 0.25 3365(E) 05.11.2013
1 Tablet 0.27 1156(E) 28.04.2014
1 Tablet 0.28 619(E) 26.02.2015
1 Tablet 1.37 3570(E) 02.12.2013
1 Tablet 1.46 1156(E) 28.04.2014
1 Tablet 1.52 619(E) 26.02.2015
(iv) Iron Dextran Injection 50mg iron/ml 1 ml 28.71 2245(E) 22.07.2013
1 ml 30.52 1156(E) 28.04.2014
1 ml 31.69 619(E) 26.02.2015
(v) Pyridoxine Tablets 10 mg 1 Tablet 0.22 2091(E) 20.08.2014
1 Tablet 0.23 619(E) 26.02.2015
10.2: Medicines affecting coagulation
(i) Heparin Sodium Injection 1000 IU/ml 1 ml 17.50 3764(E) 20.12.2013
1 ml 18.61 1156(E) 28.04.2014
1 ml 19.33 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 30 -
Note :

Injection 5000 IU/ ml 1 ml 40.62 2858(E) 20.09.2013
1 ml 43.19 1156(E) 28.04.2014
1 ml 43.53 1787(E) 10.07.2014
1 ml 45.21 619(E) 26.02.2015
(ii) Protamine Sulphate Injection 10 mg/ml 1 ml 8.92 1898(E) 28.06.2013
1 ml 9.48 1156(E) 28.04.2014
1 ml 9.84 619(E) 26.02.2015
(iii) Phytomenadione Injection 10 mg/ml 1 ml 43.82 3343(E) 05.11.2013
1 ml 46.59 1156(E) 28.04.2014
1 ml 48.38 619(E) 26.02.2015
(iv) Warfarin sodium Tablets 5 mg 1 Tablet 2.24 1621(E) 14.06.2013
1 Tablet 2.38 1156(E) 28.04.2014
1 Tablet 2.47 619(E) 26.02.2015
Added Medicines
(v) Enoxaparin Injection 40mg Each Pack 439.39 2246(E) 22.07.2013
Each Pack 467.16 1156(E) 28.04.2014
Each Pack 485.14 619(E) 26.02.2015
Injection 60mg Each Pack 530.98 1917(E) 28.06.2013
Each Pack 564.54 1156(E) 28.04.2014
Each Pack 586.27 619(E) 26.02.2015
Section: 11 -Blood products and Plasma substitutes
11.1: Plasma Substitutes
(i) Dextran-40 Injection 10% 1 ml 0.75 3344(E) 05.11.2013
1 ml 0.80 1156(E) 28.04.2014
1 ml 0.83 619(E) 26.02.2015
(ii) Dextran-70 Injection 6%
(iii) Fresh frozen plasma Injection
(iv) Hydroxyethyl Starch Injection 6% 1 ml 0.74 3366(E) 05.11.2013
(Hetastarch) 1 ml 0.79 1156(E) 28.04.2014
1 ml 0.82 619(E) 26.02.2015
(v) Polygeline Injection 3.5% 1 ml 0.53 2090(E) 20.08.2014
1 ml 0.55 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 31 -
Note :

11.2: Plasma fractions for specific use
(i) Albumin Injection 5%
Injection 20% 1 ml 36.66 1807(E) 21.06.2013
1 ml 38.98 1156(E) 28.04.2014
1 ml 40.48 619(E) 26.02.2015
(ii) Cryoprecipitate Injection --
(iii) Factor VIII Concentrate Injection Dried Each Pack 6080.43 3345(E) 05.11.2013
Each Pack 6464.71 1156(E) 28.04.2014
Each Pack 6713.54 619(E) 26.02.2015
(iv) Factor IX Complex Injection Dried
(Coagulation
Factors II,VII, IX, X)
(v) Platelet Rich Plasma Injection --
Section: 12 -Cardiovascular medicines
12.1: Antianginal medicines
(i) Acetyl salicylic acid Tablets 75mg soluble/ 1 Tablet 0.26 952(E) 27.03.2014
dispersible 1 Tablet 0.28 2095(E) 20.08.2014
1 Tablet 0.29 619(E) 26.02.2015
100mg soluble/ 1 Tablet 0.14 2360(E) 15.09.2014
350mg soluble/
dispersible
(ii) Diltiazem Tablets 30 mg 1 Tablet 2.27 1622(E) 14.06.2013
1 Tablet 2.41 1156(E) 28.04.2014
1 Tablet 2.50 619(E) 26.02.2015
1 Tablet 5.09 1156(E) 28.04.2014
1 Tablet 5.29 619(E) 26.02.2015
(iii) Glyceryl Trinitrate Sublingual Tablets 0.5 mg 1 Tablet 1.85 1623(E) 14.06.2013
1 Tablet 1.97 1156(E) 28.04.2014
1 Tablet 2.05 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 32 -
Note :

Injection 5mg/ml 1ml 7.53 1624(E) 14.06.2013
1ml 8.01 1156(E) 28.04.2014
1ml 8.32 619(E) 26.02.2015
(iv) Isosorbide 5 Mononitrate/ Tablets 10 mg 1 Tablet 1.92 1625(E) 14.06.2013
1 Tablet 2.04 1156(E) 28.04.2014
1 Tablet 2.12 619(E) 26.02.2015
1 Tablet 3.50 1156(E) 28.04.2014
1 Tablet 3.63 619(E) 26.02.2015
Isosorbide Dinitrate Tablets 10 mg 1 Tablet 0.69 2057(E) 05.07.2013
1 Tablet 0.73 1156(E) 28.04.2014
1 Tablet 0.76 619(E) 26.02.2015
1 Tablet 2.08 619(E) 26.02.2015
(v) Metoprolol Tablets 25 mg 1 Tablet 3.73 2058(E) 05.07.2013
1 Tablet 3.38 3770(E) 20.12.2013
1 Tablet 3.59 1156(E) 28.04.2014
1 Tablet 3.73 619(E) 26.02.2015
1 Tablet 5.01 3771(E) 20.12.2013
1 Tablet 5.33 1156(E) 28.04.2014
1 Tablet 5.54 619(E) 26.02.2015
Injection 1mg/ml 1 ml 2.61 2247(E) 22.07.2013
1 ml 2.77 1156(E) 28.04.2014
1 ml 2.88 619(E) 26.02.2015
Added Medicines
(vi) Clopidogrel Tablets 75 mg 1 Tablet 10.03 2060(E) 05.07.2013
1 Tablet 10.66 1156(E) 28.04.2014
1 Tablet 11.07 619(E) 26.02.2015
12.2: Antiarrhythmic medicines
(i) Adenosine Injection 3 mg/ml 1 ml 114.55 1627(E) 14.06.2013
1 ml 121.79 1156(E) 28.04.2014
1 ml 126.48 619(E) 26.02.2015
(ii) Amiodarone Tablets 100 mg 1 Tablet 6.52 1628(E) 14.06.2013
1 Tablet 6.93 1156(E) 28.04.2014
1 Tablet 7.20 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 33 -
Note :

1 Tablet 12.41 1156(E) 28.04.2014
1 Tablet 12.89 619(E) 26.02.2015
Injection 50mg/ml (3ml 1 ml 20.76 1630(E) 14.06.2013
ampoule) 1 ml 22.07 1156(E) 28.04.2014
1 ml 22.92 619(E) 26.02.2015
(iii) Diltiazem Tablets 30 mg 1 Tablet 2.27 1622(E) 14.06.2013
1 Tablet 2.41 1156(E) 28.04.2014
1 Tablet 2.50 619(E) 26.02.2015
1 Tablet 5.09 1156(E) 28.04.2014
1 Tablet 5.29 619(E) 26.02.2015
Injection 5 mg/ ml 1 ml 3.02 2843(E) 20.09.2013
1 ml 3.21 1156(E) 28.04.2014
1 ml 3.33 619(E) 26.02.2015
(iv) Esmolol Injection 10 mg / ml 1 ml 20.51 1631(E) 14.06.2013
1 ml 21.81 1156(E) 28.04.2014
1 ml 22.65 619(E) 26.02.2015
(v) Lignocaine Hydrochloride Injection 1% Each Pack 6.87 3376(E) 05.11.2013
Each Pack 7.30 1156(E) 28.04.2014
Each Pack 7.58 619(E) 26.02.2015
Injection 2% 1 ml 1.00 2248(E) 22.07.2013
1 ml 1.06 1156(E) 28.04.2014
1 ml 1.10 619(E) 26.02.2015
(vi) Procainamide Hydrochloride Tablets 250 mg
Injection 100mg/ml
(vii) Verapamil Tablets 40 mg 1 Tablet 0.47 2360(E) 15.09.2014
1 Tablet 0.49 619(E) 26.02.2015
1 Tablet 0.93 619(E) 26.02.2015
Injection 2.5mg/ml 1 ml 0.72 2360(E) 15.09.2014
1 ml 0.75 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 34 -
Note :

12.3: Antihypertensive medicines
(i) Amlodipine Tablets 2.5 mg 1 Tablet 2.03 1808(E) 21.06.2013
1 Tablet 1.79 3772(E) 20.12.2013
1 Tablet 1.90 1156(E) 28.04.2014
1 Tablet 1.97 619(E) 26.02.2015
1 Tablet 2.83 3773(E) 20.12.2013
1 Tablet 3.01 1156(E) 28.04.2014
1 Tablet 3.13 619(E) 26.02.2015
(ii) Atenolol Tablets 50 mg 1 Tablet 2.07 1810(E) 21.06.2013
1 Tablet 2.20 1156(E) 28.04.2014
1 Tablet 2.28 619(E) 26.02.2015
1 Tablet 3.96 1156(E) 28.04.2014
1 Tablet 4.11 619(E) 26.02.2015
(iii) Enalapril Maleate Tablets 2.5 mg 1 Tablet 1.78 1633(E) 14.06.2013
1 Tablet 1.89 1156(E) 28.04.2014
1 Tablet 1.96 619(E) 26.02.2015
1 Tablet 3.15 1156(E) 28.04.2014
1 Tablet 3.27 619(E) 26.02.2015
Injection 1.25mg/ml Each Pack 185.21 2357(E) 15.09.2014
Each Pack 192.34 619(E) 26.02.2015
(iv) Losartan Potassium Tablets 25 mg 1 Tablet 2.50 1635(E) 14.06.2013
1 Tablet 2.66 1156(E) 28.04.2014
1 Tablet 2.76 619(E) 26.02.2015
1 Tablet 4.57 1156(E) 28.04.2014
1 Tablet 4.75 619(E) 26.02.2015
(v) Methyldopa Tablets 250 mg 1 Tablet 1.69 3129(E) 10.12.2014
1 Tablet 1.76 619(E) 26.02.2015
(vi) Nifedipine Capsules 5 mg 1 Capsule 0.86 1900(E) 28.06.2013
1 Capsule 0.91 1156(E) 28.04.2014
1 Capsule 0.95 619(E) 26.02.2015
Capsules 10mg 1 Capsule 1.18 1637(E) 14.06.2013
1 Capsule 1.25 1156(E) 28.04.2014
1 Capsule 1.30 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 35 -
Note :

1 Tablet 1.20 1156(E) 28.04.2014
1 Tablet 1.25 619(E) 26.02.2015
1 Tablet 0.34 1156(E) 28.04.2014
1 Tablet 0.35 619(E) 26.02.2015
Sustained Release 10mg 1 Capsule 1.67 2844(E) 20.09.2013
Tablets or Capsules 1 Capsule 1.78 1156(E) 28.04.2014
1 Capsule 1.85 619(E) 26.02.2015
Sustained Release 10mg 1 Tablet 1.42 1901(E) 28.06.2013
Tablets or Capsules 1 Tablet 1.51 1156(E) 28.04.2014
1 Tablet 1.57 619(E) 26.02.2015
Sustained Release 20mg 1 Capsule 2.19 2845(E) 20.09.2013
Tablets or Capsules 1 Capsule 2.33 1156(E) 28.04.2014
1 Capsule 2.42 619(E) 26.02.2015
Sustained Release 20mg 1 Tablet 1.90 2061(E) 05.07.2013
Tablets or Capsules 1 Tablet 2.02 1156(E) 28.04.2014
1 Tablet 2.10 619(E) 26.02.2015
(v) Sodium Nitroprusside Injection 50 mg/ 5 ml Each Pack 129.98 1902(E) 28.06.2013
Each Pack 138.19 1156(E) 28.04.2014
Each Pack 143.51 619(E) 26.02.2015
Added Medicines
(vi) Hydrochlorthiazide Tablets 12.5mg 1 Tablet 0.97 1639(E) 14.06.2013
1 Tablet 1.03 1156(E) 28.04.2014
1 Tablet 1.07 619(E) 26.02.2015
1 Tablet 1.76 1156(E) 28.04.2014
1 Tablet 1.83 619(E) 26.02.2015
12.4: Medicines used in heart failure
(i) Digoxin Tablets 0.25 mg 1 Tablet 1.26 1641(E) 14.06.2013
1 Tablet 1.34 1156(E) 28.04.2014
1 Tablet 1.39 619(E) 26.02.2015
Injection 0.25 mg/ml 1 ml 2.85 3367(E) 05.11.2013
1 ml 3.74 422(E) 17.02.2014
1 ml 3.98 1156(E) 28.04.2014
1 ml 4.13 619(E) 26.02.2015
Elixir 0.05 mg/ml
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 36 -
Note :

(ii) Dobutamine Injection 50 mg / ml Each Pack 65.42 1642(E) 14.06.2013
Each Pack 69.55 1156(E) 28.04.2014
Each Pack 72.23 619(E) 26.02.2015
(iii) Dopamine Hydrochloride Injection 40 mg / ml Each Pack 5.53 1643(E) 14.06.2013
Corrigendum issued reg. S.O. 1643(E) dt. 14.6.2013 1ml 2536(E) 21.08.2013
1 ml 5.88 1156(E) 28.04.2014
1 ml 6.11 619(E) 26.02.2015
12.5: Antithrombotic medicines
(i) Acetyl salicylic acid Tablets 75mg soluble/ 1 Tablet 0.26 952(E) 27.03.2014
1 Tablet 0.29 619(E) 26.02.2015
100mg soluble/ 1 Tablet 0.14 2360(E) 15.09.2014
350mg soluble/
dispersible
(ii) Heparin Sodium Injection 1000 IU /ml 1 ml 17.50 3764(E) 20.12.2013
1 ml 18.61 1156(E) 28.04.2014
1 ml 19.33 619(E) 26.02.2015
Injection 5000 IU/ml 1 ml 40.62 2858(E) 20.09.2013
1 ml 43.19 1156(E) 28.04.2014
1 ml 43.53 1787(E) 10.07.2014
1 ml 45.21 619(E) 26.02.2015
(iii) Streptokinase Injection 750,000 IU Each Pack 1087.43 1644(E) 14.06.2013
Each Pack 1156.16 1156(E) 28.04.2014
Each Pack 1200.66 619(E) 26.02.2015
Injection 15,00,000 IU Each Pack 2034.04 1645(E) 14.06.2013
Each Pack 2162.59 1156(E) 28.04.2014
Each Pack 2245.83 619(E) 26.02.2015
(iii) Urokinase Injection 500,000IU/ml Each Pack 2028.57 1646(E) 14.06.2013
Each Pack 2490.97 3571(E) 02.12.2013
Each Pack 2648.40 1156(E) 28.04.2014
Each Pack 2750.34 619(E) 26.02.2015
Injection 10,00,000IU/ml
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 37 -
Note :

New Category - ADDED
12.6 Hypolipidemic Medicines
(i) Atorvastatin Tablets 5 mg 1 Tablet 3.82 1647(E) 14.06.2013
1 Tablet 4.06 1156(E) 28.04.2014
1 Tablet 4.22 619(E) 26.02.2015
1 Tablet 6.28 1156(E) 28.04.2014
1 Tablet 6.49 1786(E) 10.07.2014
1 Tablet 6.74 619(E) 26.02.20154
Section: 13 -Dermatological medicines (Topical)
13.1: Antifungal medicines
(i) Miconazole Ointment or 2% 1gm 2.19 1903(E) 28.06.2013
1gm 2.33 1156(E) 28.04.2014
1gm 2.42 619(E) 26.02.2015
Cream 2% 1gm 1.39 1904(E) 28.06.2013
1gm 1.48 1156(E) 28.04.2014
1gm 1.54 619(E) 26.02.2015
13.2: Antiinfective medicines
(i) Acyclovir Cream 5% 1 gm 8.88 1812(E) 21.06.2013
1 gm 9.44 1156(E) 28.04.2014
1 gm 9.80 619(E) 26.02.2015
(ii) Framycetin Sulphate Cream 0.5% 1gm 0.37 2360(E) 15.09.2014
1gm 0.38 619(E) 26.02.2015
(iii) Methylrosanilinium Aqueous solution 0.5%
Chloride (Gentian Violet)
(iv) Neomycin + Ointment 5 mg+ 1 gm 0.90 2087(E) 20.08.2014
Bacitracin 500 IU/gm 1 gm 0.93 619(E) 26.02.2015
(v) Povidone Iodine Solution or 5% 1 ml 0.39 1651(E) 14.06.2013
1 ml 0.41 1156(E) 28.04.2014
1 ml 0.43 619(E) 26.02.2015
Ointment 5% 1gm 1.64 1905(E) 28.06.2013
1gm 1.74 1156(E) 28.04.2014
1gm 1.81 619(E) 26.02.2015
(vi) Silver Sulphadiazine Cream 1% 1 Gm 0.22 2360(E) 15.09.2014
1 Gm 0.23 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 38 -
Note :

13.3: Antiinflammatory and antipruritic medicines
(i) Betamethasone Cream/Ointment 0.05% 1 gm 0.52 1015(E) 02.04.2014
Dipropionate 1 gm 0.55 2095(E) 20.08.2014
1 gm 0.57 619(E) 26.02.2015
(ii) Calamine Lotion -- 1 ml/gm 0.97 2859(E) 20.09.2013
1 ml / gm 1.03 1156(E) 28.04.2014
1 ml / gm 1.01 1792(E) 10.07.2014
1 ml / gm 1.05 619(E) 26.02.2015
13.4: Astringent Medicines
(i) Zinc Oxide Dusting Powder --
13.5: Medicines affecting skin differentiation and proliferation
(i) Coal Tar Solution 5%
(ii) Dithranol Ointment 0.1-2%
(iii) Glycerin Solution -- 1ml 0.29 3559(E) 02.12.2013
1ml 0.31 1156(E) 28.04.2014
1ml 0.32 619(E) 26.02.2015
(iv) Salicylic Acid Solution 5%
13.6: Scabicides and Pediculicides
(i) Benzyl Benzoate Lotion 25% 1ml 0.14 3560(E) 02.12.2013
1ml 0.15 1156(E) 28.04.2014
1ml 0.16 619(E) 26.02.2015
Added Medicines
(ii) Permethrin Cream 5% 1 gm 1.77 1648(E) 14.06.2013
1 gm 1.88 1156(E) 28.04.2014
1 gm 1.95 619(E) 26.02.2015
Lotion 1% 1 ml 0.90 3564(E) 02.12.2013
1 ml 0.96 1156(E) 28.04.2014
1 ml 1.00 619(E) 26.02.2015
Lotion 5% 1 ml 1.07 1649(E) 14.06.2013
1 ml 1.14 1156(E) 28.04.2014
1 ml 1.18 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 39 -
Note :

Section: 14 -Diagnostic agents
14.1: Ophthalmic medicines
(i) Fluorescein Eye drops 1%
(ii) Lignocaine Eye Drops 4%
(iii) Tropicamide Eye drops 1% 1 ml 9.60 1650(E) 14.06.2013
1 ml 10.21 1156(E) 28.04.2014
1 ml 10.60 619(E) 26.02.2015
14.2: Radiocontrast media
(i) Barium Sulphate Suspension 100% w/v
Suspension 250% w/v
(ii) Calcium Ipodate Injection 3 gm
(iii) Iopanoic Acid Tablets 500 mg
(iv) Meglumine Iothalamate Injection 60% w/v (iodine
=280 mg / ml)
(v) Meglumine Iotroxate Solution 5-8 g iodine in
100-250 ml
(vi) Propyliodone Oily, suspension 500-600mg/ml
(vii) Sodium Iothalamate Injection 70% w/v(Iodine
=420 mg/ml)
(viii) Sodium Meglumine Injection 60% w/v(Iodine 1 ml 4.92 2092(E) 20.08.2014
Diatrizoate conc.=292mg/ml) 1 ml 8.05 3132(E) 10.12.2014
1 ml 8.36 619(E) 26.02.2015
Injection 76% w/v (Iodine 1 ml 5.84 2092(E) 20.08.2014
conc.=370mg/ml) 1 ml 9.81 3132(E) 10.12.2014
1 ml 10.19 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 40 -
Note :

Section: 15 -Disinfectants and antiseptics
15.1: Antiseptics
(i) Acriflavin+Glycerin Solution --
(ii) Benzoin Compound Tincture -- 1ml 0.32 3561(E) 02.12.2013
1ml 0.34 1156(E) 28.04.2014
1ml 0.35 619(E) 26.02.2015
(iii) Cetrimide Solution 20% (conc. 1 ml 0.43 2249(E) 22.07.2013
for dilution) 1 ml 0.46 1156(E) 28.04.2014
1 ml 0.48 619(E) 26.02.2015
(iv) Chlorhexidine Solution 5% (conc.
for dilution)
(v) Ethyl Alcohol 70% Solution -- 1 ml 0.49 3766(E) 20.12.2013
1 ml 0.52 1156(E) 28.04.2014
1 ml 0.54 619(E) 26.02.2015
(vi) Gentian Violet Paint 0.5%
Paint 1% 1 ml 0.06 3767(E) 20.12.2013
1 ml 0.06 1156(E) 28.04.2014
1 ml 0.06231 619(E) 26.02.2015
(vii) Hydrogen Peroxide Solution 6% 1ml 0.05 3768(E) 20.12.2013
1ml 0.05 1156(E) 28.04.2014
1ml 0.05192 619(E) 26.02.2015
(viii) Povidone Iodine Solution 5% 1 ml 0.39 1651(E) 14.06.2013
1 ml 0.41 1156(E) 28.04.2014
1 ml 0.43 619(E) 26.02.2015
Solution 10% 1 ml 0.91 1652(E) 14.06.2013
1 ml 0.97 1156(E) 28.04.2014
1 ml 1.01 619(E) 26.02.2015
15.2: Disinfectants
(i) Bleaching Powder Powder Contains not 1 Kg 17.42 3126(E) 10.12.2014
less than 1 Kg 18.09 619(E) 26.02.2015
30%w/w
of available
chlorine
(as per I.P)
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 41 -
Note :

(ii) Formaldehyde Solution Solution Dilute 34 ml of
formaldehyde solution
with water to
produce 100 ml
(As per I.P)
(iii) Glutaraldehyde Solution 2% 1 ml 0.08 2860(E) 20.09.2013
1 ml 0.09 1156(E) 28.04.2014
1 ml 0.09346 619(E) 26.02.2015
(iv) Potassium Permanganate Crystals for -- 1 gm 0.38 3565(E) 02.12.2013
solution 1 gm 0.40 1156(E) 28.04.2014
solution 1 gm 0.42 619(E) 26.02.2015
Section: 16 -Diuretics
(i) Furosemide Injection 10 mg/ ml 1 ml 1.13 2360(E) 15.09.2014
1 ml 1.17 619(E) 26.02.2015
1 Tablet 0.34 619(E) 26.02.2015
(ii) Hydrochlorothiazide Tablets 25 mg 1 Tablet 1.66 1640(E) 14.06.2013
1 Tablet 1.76 1156(E) 28.04.2014
1 Tablet 1.83 619(E) 26.02.2015
50 mg
(iii) Mannitol Injection 10% 1 ml 0.69 2250(E) 22.07.2013
1 ml 0.23 3572(E) 02.12.2013
1 ml 0.24 1156(E) 28.04.2014
1 ml 0.25 619(E) 26.02.2015
Injection 20% 1 ml 0.35 2062(E) 05.07.2013
1 ml 0.37 1156(E) 28.04.2014
1ml 0.55 3134(E) 10.12.2014
1ml 0.57 619(E) 26.02.2015
(iv) Spironolactone Tablets 25 mg 1 Tablet 1.22 2360(E) 15.09.2014
1 Tablet 1.27 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 42 -
Note :

Section: 17 - Gastrointestinal medicines
17.1: Antacids and other Antiulcer medicines
(i) Aluminium Hydroxide + Tablet -- 1 Tablet 0.49 2355(E) 15.09.2014
Magnesium Hydroxide 1 Tablet 0.51 619(E) 26.02.2015
Suspension -- 1 ml 0.24 2348(E) 15.09.2014
1 ml 0.25 619(E) 26.02.2015
(ii) Omeprazole Capsules 10 mg 1 Capsule 2.76 1828(E) 21.06.2013
1 Capsule 2.93 1156(E) 28.04.2014
1 Capsule 3.04 619(E) 26.02.2015
20 mg 1 Capsule 3.02 1829(E) 21.06.2013
1 Capsule 3.21 1156(E) 28.04.2014
1 Capsule 3.33 619(E) 26.02.2015
40 mg 1 Capsule 6.12 3346(E) 05.11.2013
1 Capsule 6.51 1156(E) 28.04.2014
1 Capsule 6.76 619(E) 26.02.2015
(iii) Ranitidine Injection 25 mg / ml 1 ml 1.43 1157(E) 28.04.2014
1 ml 1.52 2095(E) 20.08.2014
1 ml 1.58 619(E) 26.02.2015
Added Medicines
(iv) Pantoprazole Injection 40 mg Each Pack 47.93 1653(E) 14.06.2013
Each Pack 50.96 1156(E) 28.04.2014
Each Pack 51.98 1789(E) 10.07.2014
Each Pack 53.98 619(E) 26.02.2015
(v) Famotidine Tablets 20 mg 1 Tablet 0.21 1016(E) 02.04.2014
1 Tablet 0.22 2095(E) 20.08.2014
1 Tablet 0.29 2366(E) 15.09.2014
1 Tablet 0.30 619(E) 26.02.2015
17.2: Antiemetics
(i) Domperidone Tablets 10 mg 1 Tablet 2.26 2063(E) 05.07.2013
1 Tablet 2.40 1156(E) 28.04.2014
1 Tablet 2.49 619(E) 26.02.2015
Syrup 1 mg / ml 1 ml 1.03 1654(E) 14.06.2013
1 ml 1.10 1156(E) 28.04.2014
1 ml 1.14 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 43 -
Note :

(ii) Metoclopramide Tablets 10 mg 1 Tablet 1.04 1655(E) 14.06.2013
1 Tablet 1.11 1156(E) 28.04.2014
1 Tablet 1.15 619(E) 26.02.2015
Syrup 5 mg/5 ml 1ml 0.47 1656(E) 14.06.2013
1ml 0.50 1156(E) 28.04.2014
1ml 0.52 619(E) 26.02.2015
Injection 5 mg/ml 1ml 2.09 1657(E) 14.06.2013
1ml 2.22 1156(E) 28.04.2014
1ml 2.31 619(E) 26.02.2015
(iii) Promethazine Tablets 10 mg 1 Tablet 0.93 2832(E) 20.09.2013
1 Tablet 0.99 1156(E) 28.04.2014
1 Tablet 1.03 619(E) 26.02.2015
1 Tablet 2.65 1156(E) 28.04.2014
1 Tablet 2.75 619(E) 26.02.2015
Elixir or Syrup 5 mg / 5 ml 1 ml 0.21 1552(E) 14.06.2013
3574(E) 02.12.2013
1 ml 0.22 1156(E) 28.04.2014
1 ml 0.23 619(E) 26.02.2015
1 ml 2.84 424(E) 17.02.2014
1 ml 2.99 1006(E) 02.04.2014
1 ml 3.18 1156(E) 28.04.2014
1 ml 3.30 619(E) 26.02.2015
Added Medicines
(iv) Ondansetron Tablets 4 mg 1 Tablet 4.76 2244(E) 22.07.2013
1 Tablet 5.06 1156(E) 28.04.2014
1 Tablet 5.25 619(E) 26.02.2015
1 Tablet 11.77 1156(E) 28.04.2014
1 Tablet 12.22 619(E) 26.02.2015
1 ml 7.84 1156(E) 28.04.2014
1 ml 8.14 619(E) 26.02.2015
Syrup 2 mg/5 ml 1 ml 1.04 1804(E) 21.06.2013
1 ml 1.11 1156(E) 28.04.2014
1 ml 1.15 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 44 -
Note :

Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
17.3: Antiinflammatory Medicines
Added Medicines
(i) 5-Amino salicylic Acid Tablets 400mg 1 Tablet 3.90 3368(E) 05.11.2013
(5-ASA) 1 Tablet 8.60 1005(E) 02.04.2014
1 Tablet 9.14 1156(E) 28.04.2014
1 Tablet 9.49 619(E) 26.02.2015
17.4: Antispasmodic medicines
(i) Dicyclomine Hydrochloride Tablets 10 mg
1 ml 3.14 1156(E) 28.04.2014
1 ml 3.26 619(E) 26.02.2015
(ii) Hyoscine Butyl Bromide Tablets 10 mg 1 Tablet 2.83 3347(E) 05.11.2013
1 Tablet 3.01 1156(E) 28.04.2014
1 Tablet 3.13 619(E) 26.02.2015
1 ml 10.46 1156(E) 28.04.2014
1 ml 10.86 619(E) 26.02.2015
17.5: Laxatives
(i) Bisacodyl Tablets, 5 mg 1 Tablet 0.97 2065(E) 05.07.2013
1 Tablet 1.03 1156(E) 28.04.2014
1 Tablet 1.07 619(E) 26.02.2015
1 Suppository 8.47 1156(E) 28.04.2014
1 Suppository 8.80 619(E) 26.02.2015
(ii) Ispaghula Granules -- 1 gm 0.76 1813(E) 21.06.2013
1 gm 0.81 1156(E) 28.04.2014
1 gm 0.84 619(E) 26.02.2015
- 45 -
Note :

17.6: Medicines used in diarrhorea
17.6.1 Oral dehydration salts
(i) Oral Rehydration Salts Powder for Glucose:13.5g/L 1 Gram 0.58 1692(E) 14.06.2013
solution Sodium L 1 Gram 0.84 2531(E) 21.08.2013
chloride:2.6 g/ 1 Gram 0.89 1156(E) 28.04.2014
Potassium 1 Gram 0.92 619(E) 26.02.2015
chloride:1.5 g/L
Trisodium citrate
dihydrate+:2.9 g/L
Powder for dilution
in 200ml; 500 ml;
1000ml. (As per I.P)
17.6.2 Antidiarrhoeal medicines
Medicines added
(i) Zinc Sulfate Syrup 20 mg/5ml 1ml 0.61 3126(E) 10.12.2014
1ml 0.63 619(E) 26.02.2015
Section: 18 -Hormones, other endocrine medicines and Contraceptives
18.1: Adrenal hormones and synthetic substitutes
(i) Dexamethasone Tablets 0.5mg 1 Tablet 0.19 1157(E) 28.04.2014
1 Tablet 0.20 2095(E) 20.08.2014
1 Tablet 0.21 619(E) 26.02.2015
Injection 4mg/ml 1 ml 2.51 1157(E) 28.04.2014
1 ml 2.67 2095(E) 20.08.2014
1 ml 2.77 619(E) 26.02.2015
(ii) Hydrocortisone Sodium Injection 100 mg / ml Each Pack 37.13 2233(E) 22.07.2013
Succinate Each Pack 39.48 1156(E) 28.04.2014
Each Pack 41.00 619(E) 26.02.2015
(iii) Methyl Prednisolone Injection 40 mg/ ml 1ml 62.54 2066(E) 05.07.2013
1ml 66.49 1156(E) 28.04.2014
1ml 69.05 619(E) 26.02.2015
Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 46 -
Note :

- 47 -
(iv) Prednisolone Tablets 5mg 1 Tablet 0.55 1008(E) 02.04.2014
1 Tablet 0.58 2095(E) 20.08.2014
1 Tablet 0.60 619(E) 26.02.2015
10mg 1 Tablet 0.92 1009(E) 02.04.2014
1 Tablet 0.98 2095(E) 20.08.2014
1 Tablet 1.02 619(E) 26.02.2015
20mg 1 Tablet 1.72 947(E) 27.03.2014
1 Tablet 1.83 2095(E) 20.08.2014
1 Tablet 1.90 619(E) 26.02.2015
18.2: Androgens
(i) Testosterone Capsules 40mg(as 1 Capsule 10.96 1659(E) 14.06.2013
undecanoate) 1 Capsule 11.65 1156(E) 28.04.2014
1 Capsule 12.10 619(E) 26.02.2015
Injection 25mg/ml(as
propionate)
18.3: Contraceptives
18.3.1: Hormonal Contraceptives
(i) Ethinylestradiol+ Tablets 0.03 mg+ 1 Tablet 3.05 2067(E) 05.07.2013
Levonorgesterol 0.15 mg 1 Tablet 3.24 1156(E) 28.04.2014
1 Tablet 3.36 619(E) 26.02.2015
(ii) Ethinylestradiol+ Tablets 0.035 mg+
Norethisterone 1.0 mg
(iii) Hormone Releasing IUD Levonorgesterol IUD 1 IUD 455.01 3128(E) 10.12.2014
Releasing 1 IUD 472.52 619(E) 26.02.2015
18.3.2: Intrauterine devices
(i) IUD containing Copper -- -- One 351.41 2349(E) 15.09.2014
One 364.94 619(E) 26.02.2015
Sl.No. Medicines Routeof Strengths Unit CeilingPrice S.O. Dateof
DosageForm
(1) (2) (3) (4) (5) (6) (7) (8)
Note :

Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 48 -
18.3.3: Barrier Methods
(i) Condoms -- -- 1 Condom 6.56 3348(E) 05.11.2013
1 Condom 6.97 1156(E) 28.04.2014
1 Condom 8.04 1791(E) 10.07.2014
1 Condom 8.35 619(E) 26.02.2015
18.4: Estrogens
(i) Ethinylestradiol Tablets 0.01mg 1 Tablet 2.12 1660(E) 14.06.2013
1 Tablet 2.25 1156(E) 28.04.2014
1 Tablet 2.34 619(E) 26.02.2015
Tablets 0.05mg 1 Tablet 3.53 3370(E) 05.11.2013
1 Tablet 3.75 1156(E) 28.04.2014
1 Tablet 3.89 619(E) 26.02.2015
18.5: Medicines used in Diabetes mellitus
18.5.1: Insulins and other Antidiabetic agents
(i) Glibenclamide Tablets 2.5 mg 1 Tablet 0.48 1661(E) 14.06.2013
1 Tablet 0.51 1156(E) 28.04.2014
1 Tablet 0.53 619(E) 26.02.2015
1 Tablet 1.02 1156(E) 28.04.2014
1 Tablet 1.06 619(E) 26.02.2015
(ii) Insulin Injection (Soluble) Injection 40 IU / ml
(iii) Intermediate Acting(Lente/ Injection 40 IU / ml
NPH Insulin)
(iv) Metformin Tablets 500mg 1 Tablet 1.56 1814(E) 21.06.2013
1 Tablet 1.66 1156(E) 28.04.2014
1 Tablet 1.72 619(E) 26.02.2015
Added medicines
(v) Premix Insulin 30:70 injection Injection 40IU/ml
Note :

- 49 -
DosageForm
(1) (2) (3) (4) (5) (6) (7) (8)
18.5.2 Medicines used to treat hypoglycemia
(i) Glucagon Injection 1mg/ml Each Pack 788.33 1663(E) 14.06.2013
Each Pack 838.15 1156(E) 28.04.2014
Each Pack 870.41 619(E) 26.02.2015
Added medicines
(ii) 25% Dextrose Injection 100 ml 1 ml 0.16 2068(E) 05.07.2013
1 ml 0.17 1156(E) 28.04.2014
1 ml 0.18 619(E) 26.02.2015
18.6 Ovulation Inducers
(i) Clomiphene Citrate Tablets 50mg 1 Tablet 7.93 1906(E) 28.06.2013
1 Tablet 8.43 1156(E) 28.04.2014
1 Tablet 8.75 619(E) 26.02.2015
1 Tablet 12.95 1156(E) 28.04.2014
1 Tablet 13.45 619(E) 26.02.2015
18.7 Progestogens
(i) Medroxy Progesterone Tablets 5mg 1 Tablet 2.59 1665(E) 14.06.2013
Acetate 1 Tablet 2.75 1156(E) 28.04.2014
1 Tablet 2.86 619(E) 26.02.2015
1 Tablet 5.57 1156(E) 28.04.2014
1 Tablet 5.78 619(E) 26.02.2015
(ii) Norethisterone Tablets 5mg 1 Tablet 5.07 1667(E) 14.06.2013
1 Tablet 5.39 1156(E) 28.04.2014
1 Tablet 5.60 619(E) 26.02.2015
18.8 Thyroid and antithyroid medicines
(i) Carbimazole Tablets 5mg 1 Tablet 1.77 1668(E) 14.06.2013
1 Tablet 1.88 1156(E) 28.04.2014
1 Tablet 1.95 619(E) 26.02.2015
Note :

Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 50 -
1 Tablet 3.65 1156(E) 28.04.2014
1 Tablet 3.79 619(E) 26.02.2015
(ii) Levothyroxine Tablets 50µg 1 Tablet 1.01 2069(E) 05.07.2013
1 Tablet 1.07 1156(E) 28.04.2014
1 Tablet 1.11 619(E) 26.02.2015
Tablets 100 µg 1 Tablet 1.11 1815(E) 21.06.2013
1 Tablet 1.18 1156(E) 28.04.2014
1 Tablet 1.23 619(E) 26.02.2015
(ii) Iodine Solution 8 mg / 5 ml 1ml 0.32 3128(E) 10.12.2014
1ml 0.33 619(E) 26.02.2015
Section: 19 Immunologicals
19.1: Diagnostic agents
(i) Tuberculin, Purified Injection 1 TU
Protein derivative
Injection 5 TU
19.2: Sera and immunoglobins
(i) Anti-D Immunoglobin Injection 300 µg Each Pack 2209.80 1670(E) 14.06.2013
(Human) Each Pack 2349.46 1156(E) 28.04.2014
Each Pack 2439.89 619(E) 26.02.2015
(ii) Polyvalent Antisnake Injection 10 ml Each Pack 410.56 2251(E) 22.07.2013
Venom Each Pack 436.51 1156(E) 28.04.2014
Each Pack 453.31 619(E) 26.02.2015
(iii) Antitetanus Human Injection 250 IU Each Pack 832.16 3371(E) 05.11.2013
Immunoglobin Each Pack 884.75 1156(E) 28.04.2014
Each Pack 918.80 619(E) 26.02.2015
Injection 500 IU Each Pack 1387.23 3372(E) 05.11.2013
Each Pack 1474.90 1156(E) 28.04.2014
Each Pack 1531.67 619(E) 26.02.2015
(iv) Diphtheria Antitoxin Injection 10,000 IU Each Pack 1156.00 3349(E) 05.11.2013
Each Pack 1229.06 1156(E) 28.04.2014
Each Pack 1276.37 619(E) 26.02.2015
Note :

- 51 -
DosageForm
(1) (2) (3) (4) (5) (6) (7) (8)
(v) Rabies Immunoglobin Injection 150 IU / ml 1ml 1255.84 3350(E) 05.11.2013
1ml 1335.21 1156(E) 28.04.2014
1ml 1386.60 619(E) 26.02.2015
19.3: Vaccines
19.3.1: For Universal Immunisation
(i) B.C.G Vaccine Injection -- Each Dose 5.58 2356(E) 15.09.2014
Each Dose 5.79 619(E) 26.02.2015
(ii) D.P.T Vaccine Injection -- 1 Vial 232.86 1671(E) 14.06.2013
1 Vial 247.58 1156(E) 28.04.2014
1 Vial 257.11 619(E) 26.02.2015
(iii) Hepatitis B Vaccine Injection -- 1 ml 101.09 3351(E) 05.11.2013
1 ml 107.48 1156(E) 28.04.2014
1 ml 111.62 619(E) 26.02.2015
(iv) Measles Vaccine Injection -- Each Pack 252.97 3352(E) 05.11.2013
Each Pack 268.96 1156(E) 28.04.2014
Each Pack 279.31 619(E) 26.02.2015
(v) Oral Poliomyelitis Solution -- 1 ml 52.52 2532(E) 21.08.2013
Vaccine (LA) kept in abeyance with immediate effect 3211(E) 21.10.2013
1 ml 99.90 3774(E) 20.12.2013
1 ml 106.21 1156(E) 28.04.2014
1 ml 110.30 619(E) 26.02.2015
19.3.2: For Specific Group of Individuals
(i) Rabies Vaccine Injection -- Each Pack 302.39 1672(E) 14.06.2013
Each Pack 321.50 1156(E) 28.04.2014
Each Pack 333.87 619(E) 26.02.2015
(ii) Tetanus Toxoid Injection -- Each Pack 10.29 1673(E) 14.06.2013
Corrigendum issue reg. S.O. 1673(E) dt. 14.06.2013 1 ml 431(E) 17.02.2014
1 ml 10.94 1156(E) 28.04.2014
1 ml 11.36 619(E) 26.02.2015
Note :

Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 52 -
Section: 20 - Muscle Relaxants (Peripherally acting) and Cholinesterase Inhibitors
(i) Atracurium Besylate Injection 10 mg / ml Each Pack 45.28 1674(E) 14.06.2013
Each Pack 48.14 1156(E) 28.04.2014
Each Pack 49.99 619(E) 26.02.2015
(ii) Neostigmine Tablets 15 mg 1 Tablet 4.63 3373(E) 05.11.2013
1 Tablet 4.92 1156(E) 28.04.2014
1 Tablet 5.11 619(E) 26.02.2015
Injection 0.5mg/ml Each Pack 4.04 1675(E) 14.06.2013
Corrigendum issued reg. 1675(E) dt. 14.6.2013 1 ml 2537(E) 21.8.2013
1 ml 4.30 1156(E) 28.04.2014
1 ml 4.47 619(E) 26.02.2015
(iii) Pyridostigmine Tablets 60 mg 1 Tablet 12.69 1919(E) 28.06.2013
1 Tablet 13.49 1156(E) 28.04.2014
1 Tablet 14.01 619(E) 26.02.2015
Injection 1mg/ml
(iv) Succinyl Choline Chloride Injection 50 mg/ml 1ml 6.04 3765(E) 20.12.2013
1ml 6.42 1156(E) 28.04.2014
1ml 6.67 619(E) 26.02.2015
Added drugs
(v) Vecuronium Injection 2 mg/ml Each Pack 74.58 1920(E) 28.06.2013
Each Pack 82.34 619(E) 26.02.2015
Section: 21 - Ophthalmological Preparations
21.1: Anti-infective agents
(i) Chloramphenicol Drops/Ointment 0.4%
Drops/ 1% 1ml 4.26 3353(E) 05.11.2013
1ml 4.53 1156(E) 28.04.2014
1ml 4.70 619(E) 26.02.2015
Ointment 1% 1 gm 4.26 2070(E) 05.07.2013
1 gm 4.53 1156(E) 28.04.2014
1 gm 4.70 619(E) 26.02.2015
Note :

- 53 -
DosageForm
(1) (2) (3) (4) (5) (6) (7) (8)
(ii) Ciprofloxacin Drops/ 0.3% 1 ml 1.30 1017(E) 02.04.2014
Hydrochloride 1 ml 1.38 2095(E) 20.08.2014
1 ml 1.49 3130(E) 10.12.2014
1 ml 1.55 619(E) 26.02.2015
Ointment 0.3% 1 gm 1.06 953(E) 27.03.2014
1 gm 1.13 2095(E) 20.08.2014
1 gm 1.17 619(E) 26.02.2015
(iii) Gentamicin Drops 0.3% 1 ml 0.89 954(E) 27.03.2014
1 ml 0.95 2095(E) 20.08.2014
1 ml 0.99 619(E) 26.02.2015
(iv) Miconazole Drops 1%
(v) Povidone Iodine Drops 0.6%
(vi) Sulphacetamide Sodium Drops 10% 1 ml 2.85 2861(E) 20.09.2013
1 ml 2.31 3377(E) 05.11.2013
1 ml 2.46 1156(E) 28.04.2014
1 ml 2.55 619(E) 26.02.2015
Drops 20% Each Pack 1.73 1676(E) 14.06.2013
Corrigendum issued related S.O. 1676(E) dt. 14.6.2013 1 ml 2873(E) 20.09.2013
1 ml 2.33 3378(E) 05.11.2013
1 ml 2.48 1156(E) 28.04.2014
1 ml 2.58 619(E) 26.02.2015
21.2: Antiinflammaory agents
(i) Prednisolone Acetate Drops 0.1%
1% 1ml 3.36 2360(E) 15.09.2014
1ml 3.49 619(E) 26.02.2015
(ii) Prednisolone Sodium Drops 1%
Phosphate
21.3: Local Anaesthetics
(i) Tetracaine Hydrochloride Drops 0.5%
Note :

Dosage Form
(1) (2) (3) (4) (5) (6) (7) (8)
- 54 -
21.4: Miotics and Antiglucoma medicines
(i) Acetazolamide Tablets 250 mg 1 Tablet 3.69 1816(E) 21.06.2013
1 Tablet 3.92 1156(E) 28.04.2014
1 Tablet 4.07 619(E) 26.02.2015
(ii) Betaxolol Hydrochloride Drops 0.25% 1 ml 3.99 3374(E) 05.11.2013
1 ml 4.24 1156(E) 28.04.2014
1 ml 4.40 619(E) 26.02.2015
Drops 0.5% 1 ml 6.59 1677(E) 14.06.2013
1 ml 7.01 1156(E) 28.04.2014
1 ml 7.28 619(E) 26.02.2015
(iii) Pilocarpine Drops 2% 1 ml 9.90 2862(E) 20.09.2013
1 ml 10.53 1156(E) 28.04.2014
1 ml 10.94 619(E) 26.02.2015
Drops 4%
(iv) Timolol Maleate Drops 0.25% 1ml 4.46 2252(E) 22.07.2013
1ml 4.74 1156(E) 28.04.2014
1ml 4.92 619(E) 26.02.2015
Drops 0.5% 1ml 12.07 2253(E) 22.07.2013
1ml 12.83 1156(E) 28.04.2014
1ml 13.32 619(E) 26.02.2015
21.5: Mydriatics
(i) Atropine Sulphate Drops/ 1% 1 ml 2.91 1830(E) 21.06.2013
1 ml 3.09 1156(E) 28.04.2014
1 ml 3.21 619(E) 26.02.2015
Ointment 1% 1 gm 3.24 1831(E) 21.06.2013
1 gm 3.44 1156(E) 28.04.2014
1 gm 3.57 619(E) 26.02.2015
(ii) Homatropine Drops 2% 1 ml 5.00 1678(E) 14.06.2013
1 ml 5.44 3573(E) 02.12.2013
1 ml 5.78 1156(E) 28.04.2014
1 ml 6.00 619(E) 26.02.2015
(iii) Phenylephrine Drops 5% 1 ml 4.95 2088(E) 20.08.2014
1 ml 5.14 619(E) 26.02.2015
Note :

NPPA Ceiling Price Report

Recommended

Recommended

More Related Content

What's hot

What's hot (20)

Viewers also liked

Viewers also liked (20)

Similar to NPPA Ceiling Price Report

Similar to NPPA Ceiling Price Report (20)

More from Anup Soans

More from Anup Soans (20)

Recently uploaded

Recently uploaded (20)

NPPA Ceiling Price Report